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1 INTRODUCTION 
 
1.1 Effect of hypoxia on the pulmonary vasculature 
 
The pulmonary circulation is a low-pressure and low-resistance system that receives the entire 
cardiac output of the right ventricle. A unique feature of the pulmonary circulation is an 
ability to contract in response to hypoxia in order to divert the blood-flow from poorly to well 
ventilated regions of the lung, to minimise ventilation-perfusion mismatch to allow maximal 
oxygenation of the venous blood. This phenomenon also known as hypoxic pulmonary 
vasoconstriction (HPV) is a reversible physiological response of the pulmonary vasculature to 
acute hypoxia. The first clear description of HPV was provided by von Euler and Liljestrand 
in 1946 as a result of their experiments in cats, where it was found that hypoxic ventilation 
increased the pulmonary arterial pressure. In contrast, chronic hypoxia may lead to the 
development of irreversible pulmonary hypertension in humans and animals living at high 
altitude (Fig. 1). The pathology of this disease includes vascular remodeling which involves 
hypertrophy of media of the pulmonary arteries, thus narrowing the vascular lumen and 
leading to a permanent increase in pulmonary artery pressure (Fig. 1). The increase in 
pulmonary artery pressure subsequently can lead to the development of right heart 
hypertrophy and cor pulmonale. 
1.2 Physiological characteristics of lung vasculature in acute hypoxia  
 
The mechanism of HPV is particular to the lung vasculature, since the systemic vasculature 
undergoes relaxation in response to hypoxia. The physiologically relevant sites of HPV are 
thought to be the pre-capillary pulmonary arterioles 1;2. Hypoxic pulmonary vasoconstriction 
occurs within seconds to few minutes of hypoxic exposure, and is a reversible process upon 
return to normoxic ventilation 3. In humans and adult animals, an alveolar O2 partial pressure 
(pAO2) of 60 mm Hg or lower is sufficient to initiate HPV 3. No visible vasoconstriction is 
observed at alveolar pO2 values greater than 60 mm Hg, even when the mixed venous pO2 
falls below 10 mm Hg. This implies that the stimulus for HPV is moderate alveolar hypoxia 
and is independent of the pO2 level of mixed venous blood 3. Physiological factors such as pH 
and pCO2 can affect the strength of HPV 4. The autonomic nervous system and humoral 
mediators can modulate the pulmonary vascular reactivity to hypoxia, but are not the primary 
regulators of HPV, since HPV has been shown to persist even after denervation of the lung as 
well as in isolated lung perfusion models 5. Hypoxic pulmonary vasoconstriction can be 
Introduction                                                                                                                               2 
 
localised to an area as small as an acinus or can include areas as large as one lung or both 
lungs, depending on the region of alveolar hypoxia. The increase in pulmonary arterial 
pressure (PAP) during HPV depends on the area of the lung that has been exposed to hypoxia. 
If the entire lung is exposed to hypoxia, this can result in acute hypoxia-induced pulmonary 
hypertension. However, a regional hypoxia leads to local vasoconstriction and effectively 
shifts the blood to the better ventilated areas of the lung with a very little increase in PAP 6. 
The mean PAP in healthy individuals is between 20-25 mm Hg, which can increase further at 
high altitude. In addition, exercising at high altitude can further increase PAP values to ~ 54 
mm Hg 7.  
Chronic hypoxiaAcute hypoxia
Vasoconstriction Vascular remodelingNormal pulmonary
artery  
Figure 1. Effect of hypoxia on pulmonary vasculature. Acute hypoxia leads to physiological vasoconstriction 
which helps to minimise the mismatch between ventilation with perfusion. Chronic hypoxia leads to substantial 
thickening of vascular wall resulting in narrowing of the vascular lumen. Acute hypoxia induced pulmonary 
vasoconstriction is a reversible process whereas chronic hypoxia induced vascular remodeling is an irreversible 
process upon acute re-exposure to normoxia. 
1.3 Mechanisms of pulmonary vascular adaptation to acute and chronic hypoxia 
 
The cellular and molecular mechanisms governing vascular remodeling under chronic 
hypoxia have been suggested to be different from those mechanisms that cause HPV under 
acute hypoxia, however, common mediators may exist 8. For example, an increase in cytosolic 
calcium levels during acute hypoxia leads to vasoconstriction but also acts as a stimulus for 
smooth muscle cell proliferation under chronic hypoxia which is a characteristic feature of 
vascular remodeling 8;9. Similarly, an inhibition of Kv channels at the functional level under 
acute hypoxia is accompanied by the down-regulation of Kv channel mRNA and protein 
expression under chronic hypoxia (discussed in section 1.3.1.4 and 1.3.2.2). According to the 
generally accepted view, hypoxic pulmonary vasoconstriction is an intrinsic property of the 
pulmonary vaculature and specifically resides in pulmonary arterial smooth muscle cells 10. 
Despite intensive research, the mechanisms of both HPV and vascular remodeling in lung 
have not been fully elucidated. Recent reports demonstrate the involvement of more than one 
pathway in controlling the reactivity of the pulmonary vasculature to hypoxia. While it is well 
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accepted that there is an increase in the cytoplasmic Ca2+ concentration [Ca2+]cyt in smooth 
muscle cells under hypoxic conditions, the mechanism of this increase remains an open 
question. Many hypotheses have been put forward to explain the hypoxia-induced increase in 
Ca2+ in acute HPV which are summarised in Fig. 2, and are discussed in more detail in the 
subsequent sections.  
1.3.1 Adaptation of pulmonary vasculature to acute hypoxia  
1.3.1.1 Role of endothelium  
 
Pulmonary vasoconstriction in response to acute hypoxia is biphasic, consisting of an 
immediate endothelium-independent constriction which peaks by ~10 min (phase 1) and an 
endothelium-dependent, sustained contraction phase, which peaks by ~40 min (phase 2) 7;11. 
The role of the endothelium in acute HPV has been widely discussed. It was reported by 
several investigators that the second phase of acute HPV is abolished in the absence of the 
endothelium 12. However, other reports refute the involvement of the endothelium in acute 
HPV 12. The importance of the endothelium in modulating HPV response is due to its unique 
ability to secrete both vasoconstrictors (endothelin-1 (ET-1)) and vasodilators (nitric oxide 
(NO)). The action of ET-1 on pulmonary vasculature media is due to presence of endothelin 
receptor subtypes A and B (ETA and ETB) in the smooth muscle cells 13. The significance of 
ET-1 as a potent vasoconstrictor can be judged from its use as a priming agent in various 
preparations and isolated lung perfusion models 12. The role of ET-1 in acute HPV is 
controversial 12. Some investigators have reported an increase plasma ET-1 levels under acute 
hypoxia, whereas other groups have not observed any changes in ET-1 levels under acute 
hypoxia 13. However, the role of ET-1 in chronic hypoxia is well accepted where it may play a 
role in vascular remodeling process 13. Nitric oxide is a potent vasodilator synthesised in the 
vascular endothelium by endothelial NO synthase (eNOS) from L-arginine and O2. The 
vasodilatory properties of NO are mediated by the production of the second messenger cGMP 
by activating soluble guanylate cyclase (sGC) 14. The cGMP inhibits Ca2+ entry in to cells by 
inhibiting L-type Ca2+ channels, and can also activate protein kinase G (PKG), which can 
inhibit voltage-gated Ca2+ channels directly 15;16. The sGC can also be activated by hydrogen 
peroxide, leading to vascular relaxation and NADPH oxidase-derived hydrogen peroxide can 
mediate NO production by the endothelium 17;18.  
Introduction                                                                                                                               4 
 
 
 
Figure 2.  Schematic diagram for acute hypoxic pulmonary vasoconstriction. A decreased production of 
ROS by mitochondrian or NADPH oxidases have been suggested to lead to an increase in the redox status of the 
cell towards more reduced state leading to the closure of voltage gated K+ channels and depolarisation of the 
PASMC membrane. Membrane depolarisation leads to the opening of voltage-dependent calcium channels 
(VDCC) leading to Ca2+ influx and contraction by activation of actin myosin contraction apparatus (1a, 2a). In 
addition, a decreased production of ROS can lead to HPV either by reduced availability of NO from endothelium 
or by reduced activation of sGC and hence less cGMP production (3a, 3b). Alternatively, an increased ROS 
production at complex I and III in mitochonria and NADPH oxidase can stimulate the release of Ca2+ ions from 
endoplasmic reticulum (ER) leading to vasoconstriction (1b, 2b). Hypoxia has also been shown to increase the 
ratio of NADPH/NADP leading to increased level of cADPR which activates ryanodine sensitive Ca2+ release 
channels in ER leading to vasoconstriction (4). Acute hypoxia has also been shown to increase calcium influx 
after activation of TRPC6 channel by involving VDCC (5). 
 
Hypoxia has been shown to reduce the basal production of NO by reduced availability of O2 
or by reduced production of superoxide (Fig.2) 19. But in contrast to the decrease of NO in 
HPV, there are arguments which favour its local increase, for example, a key stimulus for NO 
production is also shear stress on the vascular wall which is increased during HPV 13;20. 
1.3.1.2 Role of mitochondria-derived reactive oxygen species  
Molecular oxygen plays a vital role in oxidative phosphorylation in aerobic organisms where 
it participates in generation of high energy phosphate bonds of ATP by acting as the final 
electron acceptor of the cytochrome c oxidase complex embedded in the mitochondrial 
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membrane. During the process of electron transfer to molecular oxygen in the electron 
transport chain (ETC) in mitochondria partially-reduced and highly-reactive metabolites of O2 
are formed, such as the super-oxide (O2-) anion and hydrogen peroxide (H2O2) by one and two 
electron reduction of oxygen, respectively 21. These partially-reduced metabolites of O2 are 
often referred to as “reactive oxygen species” (ROS) or “activated oxygen species” (AOS) 
due to their considerable greater reactivities compared to molecular O2. In addition to the 
production of ROS by mitochondria, there are intracellular membrane-associated (NADPH 
oxidase, Cytochrome P-450) and soluble enzymes (xanthine oxidase) that can generate ROS 
21.  
Electron transport chain consists of four mega complexes embedded in the mitochondrial 
membrane that catalyzes the transfer of electrons from reduced flavoprotein moieties such as 
NAD(P)H and FADH2 to molecular oxygen (Fig. 3). Oxidation of NADH and FADH2 at 
complex I and complex II of the mitochondrial electron transport chain (ETC) respectively 
results in transfer of electrons by ubiquinone (enzyme Q) to complex III, and then to complex 
IV by the cytochrome c oxidase complex. Finally, electrons are transferred to molecular 
oxygen by complex IV, reducing it to H2O. The transfer of electrons to O2 is a tightly- 
controlled process to avoid the production of incompletely-reduced intermediates such as 
superoxide (O2-) and hydroxyl radicals (OH-). However, electrons can be transferred to 
molecular oxygen at complex I and III to form superoxide radicals (Fig. 3). Hypoxia affects 
many aspects of mitochondrial function and this is current discussion with regard to 
generation of ROS at complex I and III, although it is controversial whether there is an 
increase or decrease in levels of ROS in response to acute hypoxia 22. 
Pulmonary vascular tone is largely controlled by K+ channels, which maintain the membrane 
of smooth muscle cells in a relaxed resting and polarised state. Any cellular changes which 
decrease the opening of K+ channels result in depolarisation and subsequent contraction of 
smooth muscle cells. The K+ channels are sensitive to oxidation and reduction at key thiol 
residues present in the intracellular side of the membrane 23. According to the redox theory of 
oxygen sensing proposed by Weir and Archer, under normoxic conditions constitutive 
generation of ROS maintains the K+ channels in oxidised/opened state, however, after 
exposure to hypoxia the electron transport through the ETC falls, thus reducing ROS 
production leading to reduction/closure of K+ channels and depolarisation-dependent 
contraction (Fig. 2) 5;24. Thus, inhibitors of complex I and III such as rotenone and antimycin 
respectively, should mimic hypoxia and vasoconstriction, and should prevent hypoxia from 
eliciting any further response. Indeed the application of rotenone and antimycin suppresses 
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HPV; however, controversy remains concerning whether rotenone and antimycin application 
mimics hypoxia 5;25-27. Although some reports demonstrate an increase in pulmonary arterial 
pressure under normoxia upon application of rotenone, there are other reports which show no 
or very transient and smaller effects than on hypoxic induction 5;26;28. 
FMN-7(Fe-S) Cyt b562,b566-(Fe-S)-Cyt C1
Cyt a, Cyt a3
Cu    Cu
FAD-3(Fe-S)
Cyt b560
Complex I Complex III Complex IV
Complex II
Succinate
Malate
NADH
Glutamate
Q
O2-, H2O2O2O2-, H2O2O2
Rotenone
Cyt-c
H2OO2
CN- ,N3-,COAntimycin AMyxothiazol  
 
Figure 3. Schematic presentation of electron transport chain. The Mitochondrial electron transport chain 
consists of a series of electron carriers arranged spatially in the order of their increasing redox potential and 
organised in to four complexes. Arrows in the region of complexes I-IV show pathways of electron transfer 
between flavins (FMN-H2, FADH2), iron-sulfur centers (Fe-S), coenzyme Q (Q-QH2), cytochromes (c1, c a, a3) 
and molecular oxygen (O2) resulting in the formation of H2O. The main sites of ROS generation are complex I 
and III and hypoxia has been shown to affect these sites for superoxide production thus modulating HPV 
response. 
 
While it seems arguably stronger to think a decrease in electron transfer via ETC in hypoxia 
because of decreased availability of oxygen as the final electron acceptor of ETC there is also 
convincing evidence which suggests that ROS is increased during hypoxia. According to 
Schumacker et al. hypoxia causes an increase in ROS from the ubisemiquinone region of 
complex III in mitochondria which leads to rise in intracellular Ca2+ level (Fig. 2) 5;27;29;30. In 
line with this hypothesis the use of antioxidants and catalase as well as inhibitors which target 
the proximal region of complex III of ETC such as rotenone, diphenyl iodonium (DPI) and 
myxothiazol inhibited HPV without mimicking hypoxia. Moreover, the inhibitors which 
target the components of ETC distal to complex III such as cyanide (targets complex IV) did 
not abolish HPV 5;27;30. 
1.3.1.3 Role of NADPH oxidase derived ROS  
 
The NADPH oxidases are membrane-bound enzymes involved in superoxide production in 
various cell types by electron transfer from NADPH to oxygen. The classical leukocyte 
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NADPH oxidase plays an important role in host defense against bacterial and fungal 
pathogens 31;32. This phagocytic type of NADPH oxidase consists of two membrane-bound 
subunits, gp91phox and p22phox which form the flavocytochrome b558 complex (Fig. 4). 
Superoxide production by classical gp91phox   is induced by assembly of the cytosolic subunits 
such as p40phox, p47phox and p67phox with membrane-bound flavocytochrome b558 complex 
(Fig. 5). Such an assembly can be induced by the phosphorylation of p47phox 33. Rac GTPases 
are also involved in this activation process (Fig. 5). Recently, several additional isoforms of 
the membrane-bound subunit gp91phox have been described. The first described homolog of 
gp91phox, called mox1 (later NOX1), is primarily expressed in the colon, and is suggested to 
be involved in mitogenic activity 34. 
Table 1 NADPH oxidase (NOX) homologs
Binding partners Tissue distribution
p22 phox p47 phox p67phox p40phox Rac
NOX1 Yes NOXO1 NOXA1 ? ? Colon,vascular smooth muscle cells (VSM), uterus and prostate
NOX2 Yes Yes Yes Yes Yes Phagocyte,endothelium,cardiomyocytes, VSM (?) and lung
NOX3 ?
p47 phox 
or 
NOXO1
p67phox or 
NOXA1 ? ? Innere ear, Kidney, liver, lung and spleen
NOX4 (Renox) Yes ? ? ? ? Kidney, VSM, endothelium, cardiomyocytes, bone,ovary,eyes
placenta and skeltal muscle
NOX5 ? ? ? ? ? Lymphoid tissue, testis, prostate, breast and brain
Duox1 and Yes ? ? ? ? Thyroid gland cells and human bronchial epithelial cells
Duox2
NOXO1, Nox-Organizing protein 1(a homologue of p47 phox) ; NOXA1, Nox-activating protein 1 (a homolgue of p67phox) ; ?, unknown  
Modified  from: Ray R et al. Clinical science 2005; 109,217-226 
 
Additional homologs, including NOX3, NOX4 (Renox), NOX5, Duox1 and Duox2, were 
subsequently described 35-38 (Table 1). According to this new nomenclature, gp91phox is 
synonymous with NOX2. It was suggested that each of these homologs can replace gp91phox 
in the NADPH oxidase complex, and it has been demonstrated that these non-phagocytic 
NADPH oxidases releases lower amounts of superoxide 39-41. However, very recently two 
new isoforms of the cytosolic subunits p47phox and p67phox have been identified. These new 
subunits, NOXO1 and NOXA1, have been demonstrated to interact with NOX1 to generate 
significant amounts of superoxide without being activated by protein kinase C-dependent 
phosphorylation 42;43 (Table 1). Isoforms of gp91phox have been identified in different organs 
and cell types, including the colon, kidney, uterus, testis, liver, vascular smooth muscle cells, 
fibroblasts, endothelial cells, pancreatic islets and lymphocytes 31;33;39;44-46 (Table 1). 
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NOX1
NOX2 (gp91 phox)
NOX3
NOX4
Fe
FAD
NADP+ H+
NADPH
2 O2
2 O.-2
Fe
gp91 phox p22 phox
Cyt b558
 
Figure 4. Topological structure of NOX enzymes. NADPH oxidase I (NOX1), NOX3 and NOX4 share a 
similar catalytic core of well studied gp91 phox or NOX2 consisting of 6 transmembrane  helices at N-terminus. 
The histidine residues in helices 3 and 5 coordinate with the iron atoms at the centre of 2 heme molecules. The 
iron residue in the heme molecule is responsible for undergoing oxidation and reduction reaction in electron 
transfer process. The two heme moieties are located within two leaflets of the membrane bilayer thus providing 
an electron channel across the membrane. The C-terminal portion of the protein forms a globular cytoplasmic 
domain harboring the prosthetic group FAD and the binding site for NADPH.  
Modified from: Lassegue B et al. (40) 
 
NADPH oxidases have been shown to behave as oxygen sensors at least in neuroepithelial 
bodies where a role of mitochondria seems to be unimportant for oxygen sensing 5. According 
to Wolin et al. there is decreased superoxide production from NADH oxidase in hypoxia 
causing reduced stimulation of soluble guanylate cyclase (sGC) which results in 
vasoconstriction due to decreased production of cGMP (Fig. 2) 47. Thus, loss of a normoxic 
vasodilation in hypoxia resulted in HPV. The opponents of this hypothesis have shown that in 
hypoxia there is a paradoxical increase in ROS production rather than a decrease (Fig. 2). 
Marshall et al. characterised an NADPH oxidase with a low redox potential which is activated 
by hypoxia resulting in increased ROS production in isolated smooth muscle cells of 
resistance pulmonary arteries 48. Previous investigations from our laboratory suggested the 
involvement of a p47phox-containing NADPH oxidase in the regulation of vascular tone in 
acute hypoxia since p47phox knockout mice exhibit a reduced acute HPV as compared to wild 
type and gp91phox knockout mice 49. Recently it has been shown by Rathore et al. that acute 
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hypoxia activated NADPH oxidase and increased Ca2+ in PASMC and inhibitor of NADPH 
oxidase such as apocynin inhibited the acute hypoxia induced increase in Ca2+ 50. 
 
Rho GDI
p40phox
p47phoxCytosolic 
regulatory 
subunits
Rac Rac
GEF
Guanine nucleotide 
exchange
Protein Kinase 
(phosphorylation)
p67phox
Fe
Fe
Fe
2 O2
2 O.-2
Fe
p67phox
p40phox RacP
p47phox
P
Membrane 
binding
gp91 phoxp22phox
Cyt b558
NADPH
NADP+
 
Figure 5. Activation mechanism of NADPH oxidases. Two independent events are required for the activation 
of gp91phox resulting in the assembly of the cytosolic regulatory proteins (p40phox,p47phox and p67phox) with the 
flavocytochrome b558 (made up of the membrane associated catalytic subunit gp91phox and p22phox). One of the 
two events is the activation of protein kinases such as protein kinase C and AKT which phosphorylate the 
autoinhibitory region (AIR) of p47phox thus relieving its inhibition from the autoinhibitory loop and allowing 
p47phox to bind with p22phox. The second event results in replacement of GDP residue with GTP by a guanine 
nucleotide exchange factor (GEF)  resulting in conformational change of Rac protein by relieving inhibition 
from RhoGDP-dissociation inhibitor (RhoGDI) and promoting its binding with p67phox and finally resulting in 
the formation of active complex.  
 
1.3.1.4 Role of calcium channels and redox sensitive Kv channels 
According to the classical view of oxygen sensing, the calcium influx under acute hypoxia is 
mediated mainly by voltage-dependent calcium channels (such as L-type Ca2+ channels) 
which open in response to membrane depolarisation by hypoxia. However, recently it has 
been recognised that under acute hypoxia, apart from L-type Ca2+ channels, additional ion 
channels may also play a regulatory role in calcium influx. Non-selective cation channels 
have been identified as important players in the regulation of vascular tone by their role in 
mediating the entry of cations including Ca2+ and Na+ 51. Amongst other non-selective cation 
channels, the family of classical transient receptor potential (TRPC) channels has been shown 
to be expressed in pulmonary arterial smooth muscle cells (PASMC) 52;53. Moreover, TRPC6 
has recently been shown to be essential in acute hypoxic pulmonary vasoconstriction in mice. 
Genetic deficiency of TRPC6 resulted in a complete loss of hypoxic pulmonary 
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vasoconstrictor response; however, the chronic hypoxic pulmonary vasoconstrictor response 
was unaltered in these mice 54. In addition to calcium influx from the extracellular space, the 
release of calcium ions from intracellular stores such as the endoplasmic reticulum (ER)  has 
been shown to play an important role in acute HPV 55. Endoplasmic reticulum possesses 
calcium release channels termed as ryanodine receptors (RyRs) based on their ability to bind 
to the plant alkaloid ryanodine with high affinity. Hypoxia has been shown to increase the 
level of ADP ribosyl cyclase (cADPR), a metabolic product of  NAD+ 56 (Fig.2). The 
cADPR is a well-known endogenous activator of ryanodine receptor Ca2+ release channels 
present in endoplasmic reticulum (ER) and can sensitise the release of Ca2+ from the ER store. 
Based on the role of cADPR in Ca2+ mobilisation from the intracellular ER stores, Wilson et 
al. suggested that cADPR acts as an oxygen sensor in the pulmonary artery 57. Alternatively, 
Okabe et al. have suggested that the cADP-ribose system can also be regulated by 
interference with ROS, since low levels of superoxide stimulated calcium release via cADPR 
58. However, ROS mediated release of Ca2+ ions via cADP ribose system requires further 
investigation. 
Potassium (K+) is the most abundant intracellular cation in most excitable cells, including 
vascular smooth muscle cells and cardiac myocytes. The intracellular concentration of K+ in 
such cells is around 150 mM compared to the extracellular concentration, which is 5 mM 59. 
Due to the high concentration gradient, K+ ions are passively carried out of the cell according 
to the electrochemical gradient. Due to the movement of K+ ions across the insulated lipid 
bilayer, an electrical potential difference is created between the interior and exterior of the cell 
which is termed as membrane potential or Vm. Potential differences between two points that 
are separated by an insulator are larger than the differences between these points separated by 
a conductor. Thus, the lipid membrane, which is a good insulator, has a high electrical 
potential difference across the membrane which can vary between 40 and 60 mV for 
vascular smooth muscle cells. Due to this potential difference, the plasma membranes of most 
living cells exist in an electrically polarised state. The membrane potential of polarised cells is 
termed as resting membrane potential or Em 59. The Em value for pulmonary vascular smooth 
muscle cells varies between -55 to -60 mV. The negative Em value of vascular smooth muscle 
cells literally implies that the interior of the resting cell is about 60 mV more negative than 
exterior 59. 
It is generally agreed that the Em is largely determined by the ionic concentration gradients 
generated by K+ channels rather than the ion pumps 59. Thus Em is directly related to the level 
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of whole cell K+ current or IK(V), which is determined by IK(V)=  N× i ×Po, where N is the 
number of Kv channels present in the membrane, i is the single-channel Kv current, and Po is 
the steady-state open probability of the Kv channel 60. 
A decrease in K+ currents through plasmalemmal K+ channels, either by a decrease in N due 
to downregulation of the channel expression, or a decrease in Po due to the blockade of the 
channel conductance, causes membrane depolarisation (making Em more positive), whereas 
an increase in K+ currents either by an increase in the Po or N causes membrane 
hyperpolarisation (making Em more negative) 60. Any cellular changes which bring 
depolarisation in the PASMC makes the cell contract on the other hand the hyperpolarisation 
brings relaxation to PASMC. Due to the role of K+ channels in regulating the vascular tone, 
McMutry et al. suggested that HPV might be induced by inhibition of K+ channels 60.  
Functionally, K+ channels can be classified in to five groups: 1) voltage-gated K+ (Kv) 
channels, 2) Ca2+-activated K+ channels, 3) ATP-sensitive K+ channels, 4) inward rectifier K+ 
channels, and 5) voltage-insensitive background K+ channels. On the basis of the membrane 
topological structure K+  channels can be classified as: 1) channels with one pore and six-
transmembrane domains (For example, Kv channels and its subfamilies such as delayed 
rectifier K+ channels (KDR), A-type K+ channels (KA), outward rectifying, inward rectifying , 
slowly activating  and Ca2+-activated K+ channels), 2) channels with one pore and two-
transmembrane domains (For example, ATP-sensitive K+ (K+ATP) and inward rectifier K+ 
channels (Kir)), and 3) channels with two-pore and four-transmembrane domains (e.g., 
weakly inward rectifying K+ channels (TWIK)) 60-62.  
The family of K+ channels with one pore and six-transmembrane domains (Kv channels and 
Ca2+-activated K+ channels) form the largest group of Potassium channel family and have also 
been suggested to show sensitivity to hypoxia leading to HPV 60;61. However, the majority of 
reports indicate greater contribution by the Kv family in O2 sensing in PASMC 60;61. 
Functional Kv channels are either homomeric or heterotetramers consisting of pore forming  
subunits or P-subunits and cytoplasmic or regulatory  subunits (Fig.6). The  subunit 
determines the selectivity of K+ ions and is a conserved domain in all K+ channels from 
bacteria to humans 62. 
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Figure 6. Schematic drawing of the  subunit of K+ channel.  a) The  subunit forms the ionic pore in a 
tetrameric configuration. Each  subunit has six transmembrane domains. Both N and C terminal portions of  
subunit are intracellular. A positively-charged amino terminal ball domain occludes the ionic pore of K+ 
channels under hypoxic conditions resulting in their inactivation. Reactive oxygen species produced by NADPH 
oxidase can inactivate the channel by oxidising specific cysteine residues in the N-terminus which forms the 
disulfide bridges with the other cysteine residues in the channel thus occluding the pore by immobilising the 
balls. b) Cross section of the  subunit in tetrameric configuration. 
 
There are only three regulatory  subunits identified to date ( 1-3). Heteromultimeric 
association of  subunits with  subunits increases the complexity of Kv channels. The  and 
 subunits associate in a 1:1 stoichiometry thus four subunits of  associate with four subunits 
of  creating  44 heterotetramers. Homotetrameric gene products of Kv1.2, Kv2.1 and 
Kv3.1 and heterotetramers of Kv1.2/Kv1.5, Kv2.1/Kv9.3 and Kv4.2/Kv  1.2 have been 
shown to be sensitive to hypoxia (Table 2) 60;62. There are two types of K+ channels which are 
abundant in pulmonary arterial smooth muscle cells: 1) The KDR channels which open by 
membrane depolarisation and are preferentially inhibited by hypoxia and 4-AP and 2) the 
Ca2+dependent K+channel (KCa2+) which opens with membrane depolarisation and 
intracellular Ca2+ and is specifically inhibited by charybdotoxin, iberiotoxin and 
tetraethylammonium (TEA) 63. A list of various hypoxia sensitive Kv channels expressed in 
the pulmonary vasculature is given in Table 2. Proximal and distal segments of the pulmonary 
vasculature possess different electrophysiologically distinct SMC populations. Archer et al. 
have shown that the proximal portion of the pulmonary vasculature harbors a higher 
percentage of KCa2+ channels compared to the cells of the distal segment, which are enriched 
in KDR channels 63. Out of the 542 cells identified in the proximal segment, 15% were 
KCa2+cells and 15% were KDR expressing cells; however, in the distal segment 65% of a total 
of 342 cells were found to be KDR expressing cells and only 3% were KCa2+ expressing cells 
63. Due to these electrophysiologically distinct smooth muscle cell populations, different 
portions of pulmonary vasculature exhibit different reactivity to hypoxia 63. The inhibitor, 4-
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Aminopyridine, which is a blocker of KDR channels, causes membrane depolarisation and , 
increases [Ca2+]cyt induces cell contraction in the distal portion of the pulmonary vasculature 
64;65. Acute hypoxia significantly reduced whole cell IK(V) currents and caused membrane 
depolarisation in PASMC but not in smooth muscle cells of systemic arteries 66. Furthermore, 
HPV was impaired in Kv1.5 knockout mice and enhancing the expression of Kv1.5 channel 
via adenoviral gene transfer could restore HPV and the O2 sensitive K+ current in PASMC 
67;68. 
Table 2: List of various Kv  and  subunits expressed in pulmonary vasculature and channels which are 
potentially involved in oxygen sensing 
Subfamily 
Channel 
subunit 
mRNA 
expression
Protein 
expression
 Sensitivity 
to hypoxia 
     
Delayed rectifier Kv 1.1 Yes Yes  
Delayed rectifier Kv  1.2 Yes Yes Yes 
Delayed rectifier Kv  1.3 Yes Yes  
Delayed rectifier Kv  1.4 Yes Yes  
Delayed rectifier Kv  1.5 Yes Yes Yes 
Delayed rectifier Kv  1.6 Yes Yes  
Delayed rectifier Kv  1.7 Yes   
Delayed rectifier Kv  2.1 Yes Yes Yes 
Delayed rectifier Kv  2.2 Yes Yes  
Delayed rectifier Kv  3.1 Yes Yes Yes 
A-type  Kv  3.3 Yes   
A-type  Kv  3.4 Yes   
A-type  Kv  4.1 Yes   
A-type  Kv  4.2 Yes   
A-type  Kv  4.3 Yes  Yes 
Modifier/silencer * Kv  5.1 Yes   
Modifier/silencer Kv  6.1 Yes   
Modifier/silencer Kv  9.1 Yes   
Modifier/silencer Kv  9.2 Yes   
Modifier/silencer Kv  9.3 Yes  Yes 
 Kv   1.1 Yes  Yes 
 Kv   1.2 Yes  Yes 
 Kv   1.3 Yes   
 Kv   2.1 Yes   
 Heteromeric / or / channel 
 Kv  1.2/ Kv  1.5  Yes 
 Kv  2.1/ Kv  9.3  Yes 
 Kv  4.2/ Kv   1.2  Yes 
          
 
Modified from: Jason X.-J. Yuan.(60)  
* Modifiers/ silencers are unable to form functional channels but associate with the other  subunits to form 
conductive pores.  
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1.3.2 Adaptation of pulmonary vasculature to chronic hypoxia: pathomechanisms 
 
1.3.2.1 Structural changes in the pulmonary vasculature under chronic hypoxia 
 
The pulmonary vasculature undergoes morphological changes in response to chronic hypoxia, 
although the severity of these changes depends on the species, genotype, sex and 
developmental stage. Some animal species such as pikas, yaks, snow pigs and llamas are 
resistant to hypoxia-induced pulmonary vascular remodeling, whereas neonatal calves are 
highly susceptible animals to chronic hypoxia 69;70. The endothelium of the pulmonary 
vasculature undergoes minimal changes in response to chronic hypoxia in rats, however, an 
extreme elevation in the PAP is observed in neonatal calves in response to chronic hypoxia, 
where a more pronounced intimal thickening similar to humans was observed 8;70. In addition 
to vascular remodeling, some reports have indicated a reduction in the cross-sectional area of 
the pulmonary vascular bed due to loss of small blood vessels during chronic hypoxia. This 
mechanism is also known as rarefaction or pruning 71;8. 
The proximal portion of the pulmonary vasculature undergoes thickening of both media and 
adventitia in response to chronic hypoxia in large mammalian species such as cows, lambs, 
pigs and humans, however, in rodents adventitial thickening is more prominent compared to 
medial thickening 8. The media of conduit pulmonary and systemic vessels in large 
mammalian species, including humans, is more complex compared to rodents and has a 
distinct smooth muscle–like (SM-like) subpopulation residing within the media 8;72;73. This 
SM-like population exists in a relatively "undifferentiated state" in comparison to other 
smooth muscle cells within the vessel wall, and only these less-differentiated SM-like cells 
proliferate in response to hypoxic exposure 8.  
The distal portion of the pulmonary vasculature is the site of HPV and it undergoes significant 
changes in response to chronic hypoxia in both rodents and large mammalian species. This 
portion of pulmonary vasculature also has a SM-like subpopulation of the cells which exhibit 
greater proliferative response to chronic hypoxia compared to similar cells from the proximal 
portion 8. The most dramatic change that is observed in the distal portion of pulmonary 
vasculature is the muscularisation of partial and non-muscularised vessels. The distal 
muscularisation is believed to occur due to the presence of some specialised cells known as 
“pericytes” or “intermediate cells” which exhibit SM- like characteristics. These cells undergo 
proliferation and differentiation in response to chronic hypoxia and contribute to 
muscularisation of otherwise non muscularised vessels 8. 
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The mechanisms operating under chronic hypoxia induced vascular remodeling are not fully 
understood. Current reports have suggested that under chronic hypoxia there is a change in the 
endothelial and smooth muscle cell phenotype. A functional decreased production of NO from 
the endothelium has been reported under chronic hypoxia 19. Furthermore, endothelial nitric 
oxide synthase 3 (NOS3) knockout mice have been shown to exhibit increased right 
ventricular pressure and vascular remodeling under chronic hypoxia 74;75.  
Changes in smooth muscle cell phenotype includes hypertrophy, migration and excessive 
proliferation of PASMC 8. These changes in the smooth muscle cell phenotype are thought to 
be caused by the increased production of growth factors by endothelial cells under chronic 
hypoxia such as platelet derived growth factor-beta (PDGF-beta), vascular endothelial growth 
factor (VEGF), basic fibroblast growth factor (bFGF), serotonin, endothelin-1 (ET-1) and a 
loss of prostacyclin. The PDGF-beta is a potent mitogen for PASMC and it has been recently 
shown that inhibition of the PDGF receptor using STI571 (imatinib) completely reverses 
hypoxia-induced pulmonary vascular remodeling in mice 76. Similar to PDGF, ET-1 is a 
potent mitogen for PASMC and also behaves as a vasoconstrictor in isolated pulmonary 
arterial ring preparation and in isolated lung perfusion models. The use of BQ123 (an ETA 
receptor blocker) and bosentan (mixed ETA and ETB receptor blocker) caused the partial 
reversal of increased pulmonary arterial pressure induced by hypoxia in new-born lambs and 
rats respectively 13. The roles of bFGF, VEGF and serotonin have also been discussed widely 
in chronic hypoxia induced pulmonary hypertension models 8;77-82.  
1.3.2.2  Role of calcium and Kv channels   
 
The differences in the regulation of K+ ion and Ca2+ ion homeostasis under acute and chronic 
hypoxia have been reported by several investigators 55;60;83;84. Acute hypoxia-mediated 
inhibition of Kv channels in PASMC is quite evident from several reports, however under 
chronic hypoxia, this inhibition reflects a substantial down-regulation of Kv channels at both 
the mRNA and protein levels 60. Smirnov et al. provided the first evidence of reduced 
function of Kv channels under chronic hypoxia 84;85. Later, Wang et al. provided the first 
evidence of down-regulation of Kv1.1, Kv1.5, Kv2.1, Kv4.1 and Kv9.3 channels in cultured 
PASMC under chronic hypoxia, which has been confirmed by other groups 86;87. The down-
regulation of Kv channels in chronic hypoxia was also found to be specific to PASMC as 
smooth muscle cells from systemic arteries did not show any changes in Kv channel 
expression 86;87. Multiple hypotheses have been suggested explaining the regulation of Kv 
channels under chronic hypoxia, including regulation by ROS produced by NADPH oxidases 
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and transcriptional regulation by transcription factors such as HIF-1 alpha, c-jun and NF-ATc 
88. It has recently been shown that overexpression of c-jun gene significantly decreased whole 
cell Kv currents and mRNA levels of Kv1.5 channels 89. Decreased expression of Kv channels 
can modulate the proliferation of PASMC in two ways: 1) sustained inhibition of K+ efflux 
via Kv channels in chronic hypoxia leads to influx of Ca2+ ions from both extracellular and 
intracellular stores. Recent reports have suggested that Ca2+ ions not only activate the 
contractile machinery of the cell but are also responsible for the transcription of genes which 
control progression of the cell through cell cycle and hence, control cell proliferation 55 and 2) 
inhibition of K+ efflux leads to a high cytoplasmic concentration of K+ ions which attenuate 
the activity of caspases and inhibits cytochrome c release thus making the cell more resistant 
to apoptosis (Fig. 7) 59;90. 
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Figure 7. Intracellular [K+]cyt concentration influences the apoptosis of the cell. High levels of intracellular 
[K+]cyt leads to suppression of cytoplasmic caspase activity thus making the cell more resistant to apoptosis. 
Opening of K+ channels on the other hand will accelerate the apoptosis by increasing K+ efflux.  
Modified from: Remillard  C V et al. (59). 
 
In addition to the changes in the regulation of K+ ion homeostasis, substantial changes are 
observed in the regulation of calcium influx during chronic hypoxia. While under acute 
hypoxia calcium influx is due to opening of L-type voltage-gated Ca2+ channels by membrane 
depolarisation, under chronic hypoxia, the role of L-type Ca2+ channels is controversial 91. 
According to Shimoda et al., the membrane of PASMC already exists in depolarised stated 
under chronic hypoxic conditions due to highly reduced K+ efflux. In accordance, further 
membrane depolarisation had no impact on the opening of L-type calcium channels 92. 
However, there might be other pathways regulating L-type Ca2+ channels under chronic 
hypoxia which have not been implicated in vascular remodeling. Alternative mechanisms of 
calcium influx have recently been identified that are responsible for calcium influx under 
Introduction                                                                                                                               17 
 
chronic hypoxia, which include: 1) store-operated Ca2+ channels (SOC) activated by depletion 
of Ca2+ from intracellular stores and 2) receptor operated Ca2+ channels (ROC) which are 
activated by interaction of an agonist with membrane receptors 93.  
1.3.2.3 Role of NADPH oxidase and mitochondria derived ROS  
 
The role of ROS in altering smooth muscle cell phenotype by increasing hypertrophy and 
proliferation has been widely reported 94. Increased ROS production leads to oxidative stress, 
which is an imbalance between oxidant production and the antioxidant capacity of the cell to 
prevent oxidative injury 94. Recently Wu et al. have demonstrated that chronic hypoxia 
increases ROS production in cultured PASMC, however, decreases ROS production in the 
coronary arterial smooth muscle cells 95. The possible sources of increased ROS production 
under chronic hypoxia may include NADPH oxidases and mitochondria. Chronic hypoxia 
induced up-regulation of ROS via NADPH oxidases is highly likely since NADPH oxidases 
have been shown to be activated by enodthelin-1 which is up-regulated under chronic hypoxia 
96;97. Moreover, NADPH oxidases are the major ROS-producing enzymes in the vascular 
system 94;98. However, few reports exist which have addressed a role for NADPH oxidase- 
derived oxidative-stress in pulmonary hypertension. Liu et al. have recently demonstrated that 
chronic hypoxia-induced pulmonary hypertension was abolished in gp91phox knockout mice 99. 
No investigations have been performed exploring the role NOX1 and NOX4 in chronic 
hypoxia induced vascular remodeling. Increased ROS production can modulate vascular 
remodeling process by enhancing the deposition of extracellular matrix proteins 94. In 
addition, increased ROS production can activate matrix metalloproteinases (MMPs) such as 
MMP2 and MMP9, which can accelerate degradation of basement membrane and elastin in 
cultured human SMC 94. Investigations related to the role of NADPH oxidases generated 
oxidative stress under chronic hypoxia in the pulmonary vaculature are hampered by the 
unavailability of specific and safe inhibitors for long term application under chronic hypoxia. 
Most of the studies have relied on the use of DPI and apocynin, which are non-specific 
inhibitors of NADPH oxidases. Diphenyl iodonium in general is an inhibitor of 
flavocytochromes and may inhibit nitric oxide synthase (NOS), and mitochondrial ETC 98. 
However, the role of NADPH oxidases in cardiovascular diseases such as atherosclerosis, 
hypertension, myocardial infarction, ischemia-reperfusion injury has been widely discussed 
41;98;100. Moreover, the antioxidant therapy using N-acetyl cystine (NAC) has been shown to 
be effective in preventing the development of hypoxia induced pulmonary hypertension in 
chronically hypoxic rats 101. There are scanty reports in the literature which have evidenced 
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the role of mitochondria derived ROS production in vascular remodeling under chronic 
hypoxia. Zungu et al. have recently shown that mitochondrial regulatory genes are up-
regulated under chronic hypoxia in hypertrophied right heart ventricle leading to increased 
respiratory capacity and enhanced efficiency to sustain contractile function 102. In addition, 
Bonnet et al. has shown that fawn hooded rats have abnormal mitochondria which contribute 
to the pathogenesis of pulmonary arterial hypertension by activation of hypoxia inducible 
transcription factors (HIF).  
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2  AIM OF THE STUDY 
 
Against the background given in introduction, we investigated the regulation of NADPH 
oxidase homologs under chronic hypoxia by employing a mouse model of chronic hypoxia-
induced pulmonary hypertension and studied the down-stream signaling pathway of NADPH 
oxidases to assess a possible role in hypoxia-induced vascular remodeling with special focus 
on PASMC. Thus this study aimed: 
 
1) To assess whether NADPH oxidase homologs are regulated under chronic hypoxia in 
the murine lung. 
 
2) To decipher the localisation of NADPH oxidase homologs and further screening of the 
up-regulated candidates at the mRNA and protein levels. 
 
3) To assess the possible role of NADPH oxidases in the progression of hypoxia-induced 
pulmonary hypertension. 
 
4) To study the functional aspects such as proliferation and ROS production in PASMC 
with regard to NADPH oxidases. 
 
5) To elucidate the down-stream signaling pathway of candidate NADPH oxidases at a 
functional level (by electrophysiology) in isolated PASMC. 
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3  MATERIALS  
 
3.1 Western blotting   
   
Complete Roche Mannheim, Germany 
Sodium vanadate Sigma Hamburg, Germany 
PMSF Sigma Hamburg, Germany 
Rotiphorese Gel 30 
Acrylamide Roth Karlsruhe, Germany 
TEMED Sigma Hamburg, Germany 
Ammonium persulphate Sigma Hamburg, Germany 
Tris-HCl Roth Karlsruhe, Germany 
Methanol  Fluka Chemie Buchs, Swiss 
Milk powder Roth Karlsruhe, Germany 
Tween-20 Sigma Hamburg, Germany 
 
Mini-PROTEAN vertical 
electrophoresis system Bio-Rad München,Germany 
Blotting papers Bio-Rad München,Germany 
Semi dry blotting machine Keutz Labortechnik Reiskirchen,Germany 
PVDF membrane Pall Corporation Dreieich, Germany 
Medical X-Ray film Agfa Mortsel, Belgium 
X-Ray cassette (18 x 24) Kisker biotech Steinfurt, Germany 
Medical X-Ray film processor 
(curix 60) Agfa Mortsel, Belgium 
Restore plus western blot 
stripping buffer Pierce Bonn,Germany 
Full range Rainbow ™  
molecular weight marker  Bio-Rad München,Germany 
ECL plus western blot 
detecting system Amersham Freiburg, Germany 
   
3.2  siRNA and proliferation assay  
   
Xtreme transfection reagent Roche Mannheim, Germany 
NOX4 siRNA (Human) Eurogentec Seraing, Belgium 
NOX4 siRNA (Rat)  Biospring Frankfurt, Germany 
Scrambled siRNA-FITC Invitrogen Karlsruhe, Germany 
H3 thymidine Amersham Munich, Germany 
    
3.3 Cell culture   
   
Chamber slides (permanox) 8 Nunc Wiesbaden,Germany 
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well 
48-well cell culture plates Greiner bio-one Frickenhausen,Germany 
100 mm cell culture plates Greiner bio-one Frickenhausen,Germany 
DMEM Gibco Karlsruhe, Germany 
OPTI-MEM medium  Gibco Karlsruhe, Germany 
M199 SMC medium Gibco Karlsruhe, Germany 
DPBS PAN Aidenbach,Germany 
FCS     
Pipettes (10ml, 5ml) BD Falcon Heidelberg,Germany 
Antibiotic solution 
(Penicillin+Streptomycin) PAN Aidenbach,Germany 
Trypsin PAN Aidenbach,Germany 
   
3.4 RNA extraction   
   
Rneasy RNA extraction kit Qiagen Hilden, Germany 
   
3.5 RT PCR   
   
Random hexamers  Promega Mannheim, Germany 
RNAse inhibitor  Peqlab Erlangen, Germany 
Moloney murine leukemia 
virus reverse transcriptase  Invitrogen Karlsruhe, Germany 
5X RT buffer Invitrogen Karlsruhe, Germany 
0.1 M dithiothreitol Invitrogen Karlsruhe, Germany 
dNTP Peqlab Erlangen, Germany 
Thermal Cycler Biometra Goettingen, Germany 
   
3.6 Real time PCR   
   
Platinum SYBR green qPCR 
superMix-UDG Invitrogen Karlsruhe, Germany 
ROX Invitrogen Karlsruhe, Germany 
MgCl2 Invitrogen Karlsruhe, Germany 
ABI prism 7700 detection 
system  Applied Biosystem Weiterstadt, Germany 
   
3.7 Riboprobes for in situ hybridization  
   
Digoxigenin-11-uridine 
triphosphate Roche Mannheim, Germany 
5X transcription buffer  Promega Mannheim, Germany 
RNAse inhibitor  Peqlab Erlangen, Germany 
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T3 or T7 phage polymerase Promega Mannheim, Germany 
Qiagen PCR purification kit  Qiagen Hilden, Germany 
   
3.8 Non isotopic in situ hybridization   
   
Cryostat CM1850 UV Leica Microsystems Nussloch, Germany 
TissueTek Sakura Heppenheim,Germany 
Diethylpyrocarbonate Sigma Hamburg, Germany 
Proteinase K Qiagen Hilden, Germany 
Glycine Roth Karlsruhe, Germany 
Paraformaldehyde  Roth Karlsruhe, Germany 
Triethanolamine     
Ethanol 70%, 80% and 90%  Fischer Saarbrücken, Germany 
Salmon sperm DNA Sigma Hamburg, Germany 
Yeast tRNA Sigma Hamburg, Germany 
EDTA Roth Karlsruhe, Germany 
Tris.HCl Roth Karlsruhe, Germany 
Di-Natriumhydrogenphosphat 
Dihydrat Merck Darmstadt, Germany 
Kaliumdihydrogenphosphat Merck Darmstadt, Germany 
NaCl Roth Karlsruhe, Germany 
Dextran sulphate     
Blocking reagent  Roche Mannheim, Germany 
BSA Sigma Hamburg, Germany 
Triton X-100     
Alexa fluor 488 tyramide  
Molecular Probes, 
Invitrogen Karlsruhe, Germany 
Hoechst-33258  Invitrogen Karlsruhe, Germany 
Digital Cameral Fluorescence 
Microscope DSML Leica Microsystems Nussloch, Germany 
   
3.9 Histology   
   
Automated microtom RM 2165 Leica Microsystems Nussloch, Germany 
Flattening table HI 1220 Leica Microsystems Nussloch, Germany 
Flattening bath for paraffin 
sections HI 1210 Leica Microsystems Nussloch, Germany 
Tissue embedding machine EG 
1140H Leica Microsystems Nussloch, Germany 
Cooling plate EG 1150C Leica Microsystems Nussloch, Germany 
Tissue processing automated 
machine TP 1050 Leica Microsystems Nussloch, Germany 
Stereo light microscope Leica Microsystems Nussloch, Germany 
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DMLA 
Digital camera microscope DC 
300F Leica Microsystems Nussloch, Germany 
Ethanol (70%, 95%, 99,6%) Fischer Saarbrücken, Germany 
Isopropanol (99,8%) Fluka Chemie Buchs, Swiss 
Methanol Fluka Chemie Buchs, Swiss 
Formaldehyd alcohol free 
37% Roth Karlsruhe, Germany 
Roti-Histol (Xylolersatz) Roth Karlsruhe, Germany 
Xylol Roth Karlsruhe, Germany 
Hydrogen peroxide 30% Merck Darmstadt, Germany 
Cover slips 24x36mm Menzel Germany 
Paraffin embedding medium 
Paraplast Plus Sigma Aldrich Steinheim, Germany 
Mounting medium perte Medite GmbH Burgdorf, Germany 
Trypsin  Zytomed Berlin, Germany 
Avidin-Biotin-blocking kit Vector/ Linaris 
Wertheim-Bettingen, 
Germany 
Normal goat serum Alexis Biochemicals Grünberg, Germany 
Normal Rabbit Serum Alexis Biochemicals Grünberg, Germany 
Vectastain Elite ABC kit (anti 
rabbit) Vector/ Linaris 
Wertheim-Bettingen, 
Germany 
Vector VIP substrat kit Vector/ Linaris 
Wertheim-Bettingen, 
Germany 
Methylgreen counterstain Vector/ Linaris 
Wertheim-Bettingen, 
Germany 
   
3.10 SMCs isolation from precapillary pulmonary arteries (rat and mouse) 
   
Surgical instruments 
Martin 
Medizintechnik Tuttlingen, Germany 
Surgical threads, non-
absorbable, Size 5-0 Ethibond Excel Norderstedt, Germany 
Napkins Tork Mannheim, Germany 
Medical adhesive bands 3M  Durapore® St. Paul, MN, USA 
Low melting agarose Sigma Hamburg, Germany 
Fe3O4 Iron particles Sigma Hamburg, Germany 
M199 SMCs growth medium Gibco Karlsruhe, Germany 
Collagenase type IV Sigma Hamburg, Germany 
Narcorin Merial GmbH Hallbergmoos, Germany 
Physiological saline solution DeltaSelect GmbH Dreieich, Germany 
Heparin Rathiopharm GmbH Ulm, Germany 
Plastic Syringe (10ml & 20ml) Braun Melsungen,Germany 
Needle (20G, 1 
1/2",0,9x40mm) BD Microlance 
Becton Dickinson, 
Germany 
Neelde (18G,1 Unolok Horsham,U.K 
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1/2",1,20x38mm) 
DPBS PAN Aidenbach,Germany 
Catheter (for trachea & 
pulmonary artery) 
Made manually from 
BD Microlance 3 15 
or 20G shortened to 
1,5cm  
Becton Dickinson, 
Germany 
Antibiotic solution PAN Aidenbach,Germany 
   
3.11 EMSA and nuclear isolation 
 
LightShift chemiluminescent 
EMSA kit Pierce Bonn,Germany 
Biotinylated oligonucleotides Metabion  Martinsried, Germany 
Hybond-N+ nylon membrane  Amersham UK 
HEPES Sigma Hamburg, Germany 
KCl Sigma Hamburg, Germany 
EDTA,  Sigma Hamburg, Germany 
EGTA,  Sigma Hamburg, Germany 
Nonidet P-40,  Sigma Hamburg, Germany 
Glycerol  Sigma Hamburg, Germany 
 
3.12 Electrophysiology   
   
Flaming/Brown micropipette 
puller  Sutter Instrument Novato, CA, USA 
Filamented borosilicate 
capillary glass,1.2 mm OD, 
0.69 mm ID 
World Precision 
Instruments Sarasoda, FL, USA 
Axopatch 200A amplifier  Axon Instruments Foster City, CA, USA 
pClamp6 software  Axon Instruments Foster City, CA, USA 
 
3.13 Antibodies   
   
Anti rabbit-HRP labeled Promega Mannheim, Germany 
Anti mouse HRP labeled Promega Mannheim, Germany 
Cy3 labelled  SM-Actin Sigma Hamburg, Germany 
Kv1.5 and Kv2.1 Sigma Hamburg, Germany 
HIF-1 and HIF-2 Novus Biologicals Hiddenhausen Germany 
HIF-3  Abcam Cambridge, UK 
Cy3-conjugated anti-goat 
antibody  Dako Denmark 
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3.14 General Consumables 
   
Single use syringes Inject 
Luer®, 1ml, 2ml, 5ml, 10ml
Braun
 Melsungen, Germany 
Single use gloves Transaflex® Ansell, Surbiton  
Surrey, UK 
Napkins Tork Mannheim, Germany 
Pipette filter tips, blue and 
yellow 
Eppendorf 
Hamburg, Germany 
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4  METHODS 
4.1 Animals 
 
Adult male Sprague-Dawley rats (200-250 grams body weight) and mice (C57BL/6N) of 
either sex weighing 20-22 g were obtained from Charles River Laboratories (Sulzfeld, 
Germany). Animals were housed under controlled temperature (22 °C) and lighting (12/12-
hour light/dark cycle), with free access to food and water. All experiments were performed 
according to the institutional guidelines that comply with national and international 
regulations. The experiments were approved by the local ethic commission. 
4.2 Hypoxia induced pulmonary hypertension in mice 
 
Pulmonary hypertension was induced in mice by exposure to hypoxia (10 % O2) in a 
normobaric chamber for 3, 7 and 21 days. The level of hypoxia was held constant by an 
autoregulatory control unit (O2 controller model 4010; Labotect, Göttingen, Germany) 
supplying either nitrogen or oxygen. Excessive humidity in the re-circulating system was 
prevented by condensation in a cooling system. Carbon dioxide was continuously removed by 
soda lime. Cages were opened once per day for cleaning, as well as food and water supply. 
Control mice were exposed to normoxia (21 % O2) under identical conditions for 21 days. 
4.3 Isolation of mouse organs 
 
After 3, 7 and 21 days of hypoxia, the animals were euthanized by intraperitoneal injection of 
a lethal ketamine and xylazine dose, and the lungs were flushed through a catheter in the 
pulmonary artery with Krebs Henseleit buffer (125.0 mM NaCl, 4.3 mM KCl, 1.1 mM 
KH2PO4, 2.4 mM CaCl2, 1.3 mM MgCl2 and 13.32 mM glucose) at a pressure of 20 cm H2O 
at room temperature. The buffer was pre-equilibrated with a gas mixture of 3%O2, 5.3%CO2, 
balanced N2. NaHCO3 was adjusted to result in a pH of 7.4. During perfusion of the lungs, the 
buffer was allowed to drain freely from a catheter in the left ventricle. Once the effluent was 
clear of blood, lungs were dissected from the thoracic cavity and immediately frozen in liquid 
nitrogen for mRNA analysis.  
For immunohistochemistry, in situ hybridization and laser assisted microdissection, 800 μl 
pre-warmed TissueTek (Sakura Finetek, Zoeterwoude, Netherlands) was instilled into the 
airways via a tracheal cannula. After ligation of the trachea, the lungs were excised and 
immediately snap frozen in melting isopentane. Preparation of the hypoxic animals was 
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performed continuously in a hypoxic environment (10% O2). Lungs from normoxic animals 
(control) were prepared accordingly under normoxic conditions.  
The right ventricular wall (RV) was separated from the left ventricle plus septum (LV+S) to 
calculate the ratio of RV/(LV+S) of the dehydrated heart tissue. For analysis of colon, heart, 
and pulmonary arteries, these tissues and organs were removed immediately after the lungs 
have been flushed. 
4.4 Laser-assisted microdissection 
 
Laser-microdissection was performed as described previously103-106. In brief, 10 	m thick 
cryosections of TissueTek embedded mouse lungs were mounted on glass slides. After 
hemalaun staining for 30 s, sections were subsequently immersed in 70% (v/v) and 96% (v/v) 
ethanol and stored in 100% (v/v) ethanol until use. Not more than 10 sections were prepared 
at the same time to restrict storage time. Intrapulmonary vessels (~100 μm diameter) were 
microdissected under visual control using the Laser Microbeam System (P.A.L.M., Bernried, 
Germany) and isolated by a sterile 30 G needle. Needles with adherent material were 
transferred into a reaction tube containing the lysis buffer RLT (Qiagen, Hilden, Germany) 
with -mercaptoethanol. 
4.5 Isolation of RNA and cDNA synthesis 
 
The RNA was extracted from cells using spin-columns (RNeasy, Qiagen, Germany). For 
reverse transcription (RT) of extracted RNA, 1 μg of total RNA in a total volume of 10μl was 
mixed with 1μl of dNTP and 1μl of random hexamers (Promega, Mannheim, Germany) and 
denatured at 75 °C for 3 min. After cooling on ice, the following components were added to 
the samples: 4 μl of 5 RT buffer, 2 μl of 0.1 M dithiothreitol, 1μl of RNAse inhibitor 
(Peqlab, Erlangen, Germany) and 1 μl Moloney murine leukemia virus reverse transcriptase 
(MMLV) (Invitrogen, Karlsruhe, Germany) and then incubated at 25°C for 10 min and 37°C 
for 1h.  
4.6 Real-time PCR 
 
Relative quantification of NOX4 was done using ABI prism 7700 detection system (Applied 
Biosystem, Weiterstadt, Germany). All of the primers used in the real time PCR experiments 
were intron-spanning. The reaction mixture (25 μl) consists of 2 μl of cDNA (equivalent to 
20-30 ng of RNA), 12.5 μl of Platinum SYBR Green qPCR SuperMix-UDG (Invitrogen, 
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Karlsruhe, Germany), 0.5 μl of ROX, 0.2 μM each of forward and reverse primers, 2 mM 
MgCl2 and 8 μl of autoclaved water. The Ct values of NOX4 were normalized to the 
endogenous control B2M (2-microglobulin) in both mouse and human samples 107. The PCR 
cycling conditions were as follows: 50 °C for 2 min, 95 °C for 6 min, 95 °C for 5 s, 59 °C for 
5 s, 72 °C for 10 s. Specificity of the products was verified by dissociation curves and by 
analysis on an ethidium bromide-stained agarose gel. The fold change 2

Ct was calculated as 
described previously 105. The sequences of primers used in real time PCR experiment are 
given in Table 3. 
4.7 Synthesis of riboprobes for in situ hybridization 
 
Single-stranded digoxigenin (DIG)-labeled riboprobes for non-isotopic in situ hybridization 
were generated by the in vitro transcription method. The template for the generation of single-
stranded RNA probes was amplified by nested PCR. Briefly, 1 μg of the purified PCR-
amplified template harboring T3 and T7 RNA polymerase promoter sequences was mixed 
with 2 μl digoxigenin-11-uridine triphosphate (Roche, Mannheim, Germany), 4 μl of 5 
transcription buffer (Promega, Mannheim,Germany), 1 μl of RNasin (Peqlab, Erlangen, 
Germany) and 2 μl of T3 or T7 Phage polymerase (Promega, Mannheim, Germany) in a total 
reaction volume of 20 μl. The reaction mixture was incubated at 37 °C for 2 h. The RNA 
probes were purified with a Qiagen PCR purification kit (Qiagen, Hilden, Germany). 
4.8 Non isotopic in situ hybridization on mouse lung sections 
 
The non-isotopic in situ hybridization (NISH) was performed on 8 μm thick TissueTek®-
embedded mouse lung cryostat sections. The sections were heated at 55 °C for 15 min 
followed by transferring the sections in to 2 SSC buffer for 30 min at 70 °C, 
diethylpyrocarbonate-treated water for 1 min, Proteinase K (5 μg/ml) for 10 min at room 
temperature, 0.2% (m/v) glycine in PBS solution (for the inactivation of Proteinase K) for 
30 s, PBS for 30 s, freshly prepared cold 4% (m/v) paraformaldehyde for 20 min, PBS for 
5 min, 0.1 M acetylated triethanolamine (0.5 ml of acetic anhydride/200 ml of 
triethanolamine) on a shaking platform for 10 min, PBS for 3 min, followed by dehydration of 
slides by passing through 70% (v/v), 80% (v/v) and 90% (v/v) ethanol (each for 2 min). The 
slides were then pre-hybridized with 2 Prehyb solution (1 M NaCl, 0.02 M Tris (pH 7.5), 2 
Denhardt’s reagent, 2 mM EDTA, 10 mg/ml salmon sperm DNA, 0.2 mg/ml yeast tRNA) at 
55 ° C for 2-3 h in a humidified chamber, followed by hybridization with a denatured 
antisense NOX4 probe in 2 hybridization solution (1 M NaCl, 0.02 M Tris (pH7.5), 2 
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Denhardt’s reagent, 2 mM EDTA, 2 g dextran sulphate, 0.2 mg/ml yeast tRNA) at 55 °C for 
overnight. The following day, slides were washed from low to very highly stringent 
conditions as follows: on shaking platform 2 SSC for 1 h at room temperature, 0.1 SSC at 
60 °C and finally to pre-heated 0.1x SSC (at 60 °C), followed by incubation at room 
temperature. The sections were treated with blocking buffer (2% Blocking reagent (Roche, 
Mannheim, Germany), 0.1% (m/v) BSA, 0.1 M Tris (pH 7.5), 5 M NaCl) for 30 min at room 
temperature, followed by incubation with a peroxidase-labeled anti-DIG antibody (Roche, 
Mannheim, Germany) in 1:20 dilution for 2 h at room temperature. After antibody incubation, 
sections were washed in TBT buffer (50 mM, 1 M Tris-HCl (pH 7.5), 150 mM NaCl and 
0.1% Triton X-100; 3  15 min). The fluorescent substrate Alexa fluor 488 tyramide 
(Molecular Probes, Invitrogen, Karlsruhe, Germany) at a dilution of 1:60 in amplification 
buffer was applied to the sections for 2 h. Subsequently, sections were washed (3  20 min) in 
PBT buffer (PBS, 0.1% (v/v) Tween 20) and incubated with a mouse monoclonal Cy3-labeled 
-smooth muscle actin antibody (Sigma, Hamburg, Germany) at 1:500 in PBS, for 1 h. The 
sections were washed (3  3 min) in PBS and subsequently incubated with Hoechst-33258 
(1:10.000 in PBS; Invitrogen, Karlsruhe, Germany) for 10 min, washed and mounted in 
carbonate-buffered glycerol (pH-8.6). 
4.9 Immunofluorescence on mouse lung sections 
 
Cryosections (10 μm) were fixed in ice-cold acetone for 10 min and unspecific binding of 
primary antibodies was blocked by incubation with 50% (v/v) heat-inactivated normal swine 
serum in phosphate buffered saline (9.1 mM dibasic sodium phosphate, 1.7 mM monobasic 
sodium phosphate and 150 mM NaCl, pH 7.4 (PBS)) with double the salt concentration 
(PBS+S) for 1 h. Incubation was performed overnight with an affinity-purified rabbit 
polyclonal anti-NOX4 antibody diluted 1:200, together with a mouse monoclonal FITC-
conjugated -smooth muscle actin antibody (clone 1A4, 1:500; Sigma, Deisenhofen, 
Germany) in PBS+S 108. After washing in PBS, the sections were incubated with a Cy3-
conjugated donkey anti-rabbit antibody (Chemicon, Hofheim, Germany) diluted 1:2000 in 
PBS+S for 1 h, and after a final wash step, the sections were mounted with carbonate-
buffered glycerol, pH 8.6. To test specificity, the NOX4 antibody was pre-incubated for 1 h 
with the corresponding peptide antigen (20 μg/ml). All labeling reported here was specific as 
judged from its absence in sections incubated with pre-adsorbed antibody. Immunoreactivity 
was evaluated using an Axioplan 2 imaging epifluorescence microscope (Zeiss, Göttingen, 
Germany) equipped with a Axiocam digital camera, Axiovision software (Zeiss, Göttingen, 
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Germany), and with appropriate filter sets for Cy3 and FITC or with a TCS-SP2 AOBS 
confocal laser scanning microscope (Leica, Heidelberg, Germany). 
4.10 Quantitative analysis of mouse lung sections 
 
Examination of sections was performed blinded. For every animal, 50 -smooth muscle actin-
immunoreactive vessels were evaluated for anti-NOX4-immunoreactive cells in the vessel 
wall, and the vessel diameter was measured using the Axiovision software. To restrict 
analysis to smaller blood vessels, vessels with a diameter larger than 60 μm were not 
examined.  
4.11 Immunohistochemistry on human lung sections 
 
Lung tissue samples from healthy individuals and from patients with IPAH were formalin-
fixed, paraffin-embedded and cut into 3 μm sections. After deparaffinization, rehydration and 
blocking of endogenous peroxidase, proteolytic antigen retrieval was performed (Digest All 2, 
Zytomed, Berlin, Germany). After incubation with normal goat serum for 1 h, the tissue 
sections were incubated overnight at 4 °C with primary custom-made rabbit anti-human 
NOX4 polyclonal antibody. Signal amplification was achieved with a biotinylated goat anti-
rabbit IgG secondary antibody employing the avidin-biotin-horseradish peroxidase method 
(Vectastain Elite ABC Kit, Vector/ Linaris, Wertheim-Bettingen, Germany). The purple 
chromogen Vector VIP was used to visualize immune complexes, and nuclear counterstaining 
was performed with methyl green (both from Vector/ Linaris, Wertheim-Bettingen, 
Germany). 
4.12 Western blotting  
 
Protein extracts for western blotting from human lung were prepared in RIPA buffer 
(containing 1 mM sodium vanadate, Protease-Inhibitor Mix complete (Roche, Mannheim, 
Germany) and 0.1 mM PMSF). The permission to use human tissue was obtained from local 
ethic commission. The proteins were denatured in the presence of -mercaptoethanol and 1X 
LDS sample buffer (Nu PAGE, Invitrogen, Karlsruhe, Germany) at 100°C for 10 min. For 
NOX4 immunoblot equivalent amounts of protein were resolved on 10% SDS polyacrylamide 
gels at 100V, 400 mAmp, and 150W for 90 min. Proteins were transferred to polyvinylidene 
fluoride (PVDF) membranes (Pall Corporation, Dreieich, Germany) by semi-dry electro-
blotting at 100V, 115 mAmp, and 150W for 75 min. Nonspecific antibody binding was 
blocked by incubation in 6% (m/v) non-fat dry milk powder in T-TBS (20 mM Tris-Cl, pH 
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7.5, 150 mM NaCl, 0.1% (v/v) Tween 20) at room temperature for 1 h. Incubation with a 
1:5000 diluted custom made rabbit polyclonal anti-NOX4 primary antibody was performed at 
4 °C overnight 109.After washing the membranes in T-TBS buffer, specific immunoreactive 
signals were detected by enhanced chemiluminescence (ECL, Amersham, Freiburg, 
Germany) using a secondary antibody coupled to horseradish-peroxidase.  
4.13  Human, rat and mouse cell culture 
 
Smooth muscle cells from human, rat and murine pulmonary arteries were isolated and 
cultured as described previously110;111. For the investigation of the effect of hypoxia on NOX4 
mRNA levels, cells were either exposed to 1% O2 (hypoxia) or to 21% O2 (normoxia). 
4.14  Immunocytochemistry of murine pulmonary arterial smooth muscle cells 
 
Isolated PASMC were cultured on chamber slides, treated as indicated, fixed in acetone and 
methanol (1:1), and blocked with 3% (m/v) BSA in PBS for 1 h, followed by overnight 
incubation with an anti-NOX4 antibody (1:25) diluted in 3% (m/v) BSA in PBS. Indirect 
immunofluorescence was obtained by incubation with a Cy3-conjugated anti-goat antibody 
(Dako, Denmark) diluted 1:100 in PBS, for 90 min. Nuclear counterstaining was performed 
with Hoechst-33258 (1:10.000 dilution in PBS) (Invitrogen, Karlsruhe, Germany) for 10 min. 
4.15 RNA interference and proliferation assay for human PASMC 
 
Human pulmonary arterial smooth muscle cells (10,000 cells per well) from passage five were 
cultured in 48-well tissue culture plates, and used for the RNA interference and proliferation 
assays. Transfection of NOX4 siRNA was performed in low-serum and antibiotic-free 
medium (1% (v/v) FCS in DMEM). The medium was changed at least 4 h before transfection. 
Approximately 100 nM of NOX4 siRNA (Eurogentec, Seraing, Belgium) was transfected 
using 1 μl X-tremeGENE siRNA Transfection Reagent (Roche, Mannheim, Germany) per 
cm2 of the well. Both siRNA and transfection reagent were diluted in OPTI-MEM medium 
(Gibco, Karlsruhe, Germany). For controls, a FITC-labelled, scrambled siRNA (Invitrogen, 
Karlsruhe, Germany) was employed. After five hours of transfection, the medium was 
changed to low-serum medium containing antibiotics (1% (v/v) FCS, 1% (m/v) penicillin and 
streptomycin in DMEM and incubated overnight for cellular synchronisation. The following 
day, the cells were stimulated with smooth muscle cell medium (Promocell, Heidelberg, 
Germany) supplemented with medium containing 5% (v/v) FCS and 1% (m/v) penicillin and 
streptomycin for 20 h, followed by 3H-thymidine (Amersham, Munich, Germany) addition for 
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4 h. Subsequently, cells were washed 3 with ice-cold PBS and lysed with NaOH on a shaker 
for 4 h. The radioactivity in the lysate was measured by liquid scintillation counting 
(Rotiszint® eco plus, Roth, Germany) with a Packard liquid scintillation counter.  
4.16  ROS measurement and quantification 
 
ROS in human PASMC were measured using superoxide sensitive dye DHE 
(Dihydroethidium, Invitrogen). The cells were grown on chamber slides at the density of 
10.000 /cm2, transfected with scrambled and NOX4 siRNA and incubated in normoxic and 
hypoxic chambers for 24 h. After 24 h the cells were incubated with 5 μM of DHE for 15 min 
in normoxic and hypoxic chamber. Subsequently the cells were washed in PBS, fixed in 
acetone and methanol mixture (1:1) for 10 min and stained with nuclear stain Hoechst-33258. 
The cells were visualized under a fluorescent microscope (excitation: 514 nm; emission: 560 
nm). A total of eight images was captured from each group in a blinded fashion and were 
quantified using Image J software (U.S. National Institutes of Health, Bethesda, MD). 
 
ROS measurement in isolated rat PASMC (passage two or three) was done using oxidation 
sensitive dye Dichloroflourescein diacetate (DCF-DA). The cells were grown on 6 well 
plates. The treatment of rat PASMC with NOX4 siRNA was done as described in previous 
section. At the conclusion of treatment, the cells were incubated with 10μM DCF-DA 
dissolved in HEPES-Ringer buffer (HRB (in mM): 136.4 NaCl, 5.6 KCl, 1 MgCl2, 2.2 CaCl2, 
10 HEPES, 5 glucose, 0.1% BSA, pH 7.4) in the dark for 5 min at room temperature. The 
cells were subsequently washed twice and fluorescence was measured with Infinite 200 
microplate reader (TECAN, Crailsheim, Germany) at excitation/emission wavelength of 
502/530 respectively. The flourescence values were collected from 12 different areas of well.  
The cells were stimulated with 20 nM of ET-1 and recordings were made immediately (0 
min), 5 min and after 10 min of ET-1 stimulation. 
 
4.17  Immunofluorescence on rat lung sections 
 
Immunofluorescence was performed on 8 μm thick cryosections from the rat lung. The 
cryosections were dried at room temperature for 1 h, then fixed in acetone/methanol mixutre 
(1:1) for 10 min, dried at room temp for 1 h and subsequently blocked by 3% BSA in PBS for 
1 h at room temperature.After completion of the blocking step, the sections were incubated 
with the directly labelled primary antibodies overnight at 4oC. Subsequently the sections were 
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washed 2-3 times in PBS and refixed in 4% PFA in PBS for 15 min at room temperature, 
washed with PBS and mounted using DAKO (DAKO, Denmark) fluorescent medium. All 
fluorescent slides were stored at 4oC. 
The direct labelling of primary NOX4 (custom made), Kv2.1 (Sigma, Hamburg, Germany) 
and Kv1.5 (Sigma, Hamburg, Germany) antibodies was done using rabbit IgG tricolor 
labelling kit (Invitrogen, Karlsruhe, Germany) according to manufacturers instructions. The 
labeled reaction mix was diluted up to 100μl with 3% BSA in PBS. 
4.18  Hypoxic exposure, siRNA and apocynin treatment of rat PASMC 
 
Rat PASMC were exposed to hypoxia (1% O2, 5% CO2) in 1% (v/v) FCS and 1% (m/v) 
penicillin and streptomycin M199 medium for indicated period of time. Rat PASMC were 
transfected with two different sequences of siNOX4. Approximately 100 nM of Cy3 labeled 
NOX4 siRNA (Biospring-Frankfurt, Germany) was transfected using X-tremeGENE siRNA 
transfection reagent (1:200 dilution) (Roche, Mannheim, Germany). Following NOX4 siRNA 
sequences were used: siNOX4 seq-1: GGUGUCUGCAUGGUGGUGGUAUU, siNOX4 seq-
2: CGAGAGACUUUACCGAUGCAUCAUGAUGC. Both siRNA and transfection reagent 
were diluted in OPTI-MEM medium (Gibco, Karlsruhe, Germany). For controls, a similar 
Cy3 labeled, scrambled siRNA (Biospring-Frankfurt, Germany) was employed. After five 
hours of transfection, the medium was changed to low-serum medium containing antibiotics 
(1% (v/v) FCS, 1% (m/v) penicillin and streptomycin) in M199 and were left under normoxic 
conditions for 3-days to bring down the level of NOX4 protein. After this 3-day incubation 
period, the hypoxic group of the cells was transferred to hypoxic conditions (1% O2, 5% CO2) 
for the indicated period of time whereas normoxic group of the cells stayed under normoxia 
(21% O2, 5% CO2).  
For apocynin experiment, the rat PASMC were treated with the indicated concentration of 
apocynin dissolved in 1% (v/v) FCS and 1% (m/v) penicillin and streptomycin M199 medium 
and then were transferred under normoxic and hypoxic incubator (1% O2) for three days. The 
control group of cells was treated with DMSO (di-methyl sulfoxide) solvent control in the 
similar manner.  
4.19  Electrophysiology 
 
Electrodes for whole cell recording were pulled on a Flaming/Brown micropipette puller 
(Model P-87, Sutter Instrument, Novato, CA, USA) from filamented borosilicate capillary 
glass (1.2 mm OD, 0.69 mm ID, World Precision Instruments, Sarasoda, FL, USA). The 
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electrodes were fire-polished, and resistances were 2–5 M for voltage-clamp experiments 
using above-mentioned solutions. Membrane potentials (Vm) were recorded in the current-
clamp mode at the moment of establishment of a whole cell configuration. Input resistance 
(Rm) was calculated at –70 mV as 1/slope of the current trace evoked by a ramp voltage from 
–160 to 100 mV in the voltage-clamp mode. Membrane potential and membrane currents were 
recorded with an Axopatch 200A amplifier (Axon Instruments, Foster City, CA). Signals were 
obtained at sampling rates of 5 kHz, filtered at 2 kHz and stored on the hard disk of a personal 
computer. Stimulus generation and data acquisition were controlled with the ClampEx 
program in the pClamp6 software package (Axon Instruments). Before seals were made on 
cells, liquid junction potentials were nulled for each individual cell with the Axopatch 1C 
amplifier.  The series resistances were primarily under 10 M. Current traces in voltage clamp 
were leak-subtracted.  
The bath or extracellular solution used for the voltage-clamp experiments contained (in mM) 
130 NaCl, 3 KCl, 1 CaCl2, 1 MgCl2, 10 HEPES, and 10 glucose and pH was adjusted to 7.4 
with NaOH. The pipette solution contained (in mM) 138 KCl, 0.2 CaCl2, 1 MgCl2, 10 HEPES 
(Na+ salt), and 10 EGTA and pH was adjusted to 7.4 with Tris. Osmolarity of all solutions 
was adjusted to 290 mOsm. All recordings were performed at room temperature (22–24°C). 
The rat PASMC in passage one or two were transfected with NOX4 siRNA and were exposed 
to normoxic or hypoxic conditions as described in previous sections. At the conclusion of the 
treatment, the cells were trypsnized, re-suspended in extracellular solution and were kept in 
the incubator at 37°C for 1-2 h to adhere at the bottom. The cells that were exposed to 
hypoxia were kept in the hypoxic incubator during this period. The cells at this stage look flat 
and round with a prominent nucleus and still do not gain their normal morphology. For 
dissecting out the current specific to Kv1.5 and Kv2.1 channels, the antibodies against both 
channels were dissolved in the pipette solution at the dilution of 1:100. The control 
experiments were done without any antibody in the pipette solution. The current specific to 
KDR channels was analysed using custom made software (designed by Dr. Xiang Q Gu at the 
University of California San Diego (UCSD)) which averaged 21 data points shortly before the 
termination of voltage commands.  
4.20  Calcium measurement 
 
Calcium measurement was done on isolated rat PASMC.  PASMC on coverslips were loaded 
with fura-2 acetoxymethyl ester (5 μM) in Hepes-Ringer buffer (HRB; 136.4mM NaCl/5.6 
mM KCl/1 mM MgCl2/2.2 mM CaCl2/10 mM Hepes/5 mM glucose/0.1% BSA, pH 7.4) at 
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37°C for at least 60 min. Coverslips were then placed on the inverted microscope in an open 
heating chamber maintained at 36 oC. PASMC were stimulated with 20nM entohtelin-1 
directly in the medium. Cells were analysed using a Polychrome II monochromator and an 
IMAGO CCD camera (Till Photonics, Martinsried, Germany) coupled to an inverted 
microscope (IX70; Olympus, Hamburg, Germany) at 340 and 380 nm for measuring [Ca2+]i. 
 
4.21  Statistics 
 
Values are given as mean ± SEM (Standard Error of the Mean) if not indicated differently. 
Statistical significance of the data in the western blotting, electrophysiology, ROS 
measurement and proliferation assay was calculated by two tailed student’s t-test. Comparison 
of the groups in the real time PCR experiments was done by one way ANOVA using LSD 
test. For NOX4 quantification in mouse lung sections, two conditions were evaluated: 1) is 
the number of NOX4 immunoreactive vessels different between the groups and 2) is the mean 
diameter of NOX4 immunoreactive vessels different between the groups. Statistical analysis 
was performed by a non-parametric variance analysis (Kruskal-Wallis-test). If p in this test 
was < 0.05, a comparison of the groups amongst each other was done using a Mann-Whitney-
test, where p < 0.05 was regarded as significant. Comparison of groups was stopped after 
p > 0.05 to prevent -inflation. A p-value of less then 0.05 was considered significant in all 
experiments. 
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Table 3: Nucleotide sequences of primers used for quantitative real time PCR 
Organism Primer Orientation Sequence 
Accession 
Number 
Mice NOX1 Sense 5´-TGGCTAAATCCCATCCAGTC-3´ NM_172203 
  Antisense 5´-CCCAAGCTCTCCTCTGTTTG-3´  
 NOX2 Sense 5´-TCGCTGGAAACCCTCCTATG-3´ NM_007807 
  Antisense 5´-GGATACCTTGGGGCACTTGA-3´  
 NOX4 Sense 5´-ACTTTTCATTGGGCGTCCTC-3´ NM_015760 
  Antisense 5´-AGAACTGGGTCCACAGCAGA-3´  
 p22phox  Sense 5´-CAGATCGAGTGGGCCATGT-3´ NM_007806 
  Antisense 5´-AGCACACCTGCAGCGATAGA-3´  
 p47phox Sense 5´-GTCCCTGCATCCTATCTGGA-3´ NM_010876 
  Antisense 5´-TATCTCCTCCCCAGCCTTCT-3´  
 p67phox Sense 5´-CAGACCCAAAACCCCAGAAA-3´   NM_010877 
  Antisense 5´-AGGGTGAATCCGAAGCTCAA-3´  
 p40phox Sense 5´-TTTGAGCAGCTTCCAGACGA-3´ NM_008677 
  Antisense 5´-GGTGAAAGGGCTGTTCTTGC-3´  
 NOXO1 Sense 5´-TTCCTGATGCTCCATTGCTG-3´ NM_027988 
  Antisense 5´-GGTTGGGATAAGGGCTCCTC-3´  
 NOXA1 Sense 5´-AGCTGCAGAGGTTCCAGGAG NM_172204 
  Antisense 5´-GATGTCTTGAGCCCCCTCTG  
 B2M Sense 5´-AGCCCAAGACCGTCTACTGG-3´ NM_009735 
  Antisense 5´-TTCTTTCTGCGTGCATAAATTG-3´  
Human NOX4 Sense 5´-GGTTAAACACCTCTGCCTGTTC-3´ NM_016931 
  Antisense 5´-CTTGGAACCTTCTGTGATCCTC-3´  
 B2M Sense 5´-CTGTGCTCGCGCTACTCTCT-3´ NM_004048 
  Antisense 5´-CTTCAATGTCGGATGGATGAA-3´  
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5  RESULTS 
 
5.1 NADPH oxidases in hypoxia induced pulmonary hypertension
5.1.1 Hypoxic regulation of NADPH oxidase subunits in mouse lungs 
 
The hypoxic regulation of various NADPH oxidase subunits was investigated by real time 
PCR in the lung homogenate of the mice exposed to 3 days and 3 weeks of hypoxia. Real time 
PCR measurement showed that NOX4 was the only non phagocytic NADPH oxidase 
significantly up-regulated in homogenised tissue over the time-course of exposure to chronic 
hypoxia (Fig. 8 a, b). In contrast NOX2, NOXA1, and p67phox were not significantly 
regulated and NOX1 as well as the other cytosolic NADPH oxidase subunits exhibited an 
overall down-regulation after 21 days of chronic hypoxia (Fig. 8 a, b).  
 
Figure 8. Real time PCR quantification of NADPH oxidase subunits in homogenised lungs after 3 days 
and 3 weeks of hypoxia. 
Real time PCR quantification of NADPH oxidase subunits in the lung homogenate after 3 days a) and 3 weeks of 
hypoxia b). * indicate significant difference compared to normoxic controls; boxes: percentiles 25 and 75, black 
bar: median, whiskers: percentiles 0 and 100, O = value is more than 1.5 lengths of a box away from the edge of 
a box. n= 3 mice for 3-days hypoxia; n=5 mice for 3-weeks hypoxia. 
5.1.2 Regulation of NOX2 and NOX4 in microdissected mouse pulmonary arteries 
during the course of hypoxia  
 
Considering that NOX4 was prominently up-regulated and NOX2 was previously suggested 
to play an important role in hypoxia-induced pulmonary hypertension 99, further invesigations 
were made regarding the expression of NOX4 and NOX2 in microdissected small pulmonary 
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arterial vessels (~100 μm diameter), the major site of pulmonary vascular remodeling in 
chronic hypoxia by real-time PCR (Fig. 9 a, b, c).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. NOX4 and NOX2 mRNA quantification of microdissected pulmonary arteries by real time PCR 
during development of hypoxia-induced pulmonary hypertension 
a, b) Microdissected small pulmonary arteries (~100 μm diameter) from cryosections of mouse lungs were 
employed for the quantification of NOX4 and NOX2 mRNA. Mice were maintained under normoxic or hypoxic 
conditions for up to 21 days. The NOX2 and NOX4 mRNA levels were quantified by real-time PCR normalized 
to 2-microglobulin mRNA levels. c) Delta Ct values of NOX4 and NOX2 from microdissected pulmonary 
arteries of normoxic mice. Values are duplicate measurements of n=16 vessels from n=3 lungs each. d) Right 
ventricular hypertrophy after exposure of mice to chronic hypoxia. The right ventricle (RV) to left ventricle (LV) 
+ septum (S) ratio was quantified from mouse hearts after exposure to chronic hypoxia (10% O2 for 3, 7 and 21 
days, respectively, n=5). * indicate significant differences as compared to normoxic controls, p<0.05. 
 
Comparing these vessels from animals exposed to normoxic (21% O2) and chronic hypoxic 
(10% O2) conditions for up to 3, 7 and 21 days, it was observed that NOX4 mRNA expression 
was up-regulated in the pulmonary arteries over the course of exposure to hypoxia, with the 
highest elevation after 3 weeks (Fig. 9 a). In contrast to NOX4, no regulation of NOX2 was 
observed (Fig. 9 b).  
Under normoxic conditions NOX2 mRNA levels were not different from those of NOX4  
(Fig. 9 c). The hypoxic up-regulation of NOX4 paralleled the development of pulmonary 
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hypertension in mice induced by chronic hypoxia. The ratio of the right to the left ventricular 
mass was 0.27 ± 0.01 in mice maintained under normoxic conditions, and increased to 0.28 ± 
0.03, 0.31 ± 0.02, and 0.37 ± 0.01 (n=5 each) after 3, 7 and 21 days of hypoxia, respectively 
(Fig. 9 d).  
5.1.3 Localisation of NOX4 by in situ hybridization on mouse lung sections 
 
Further investigations by in situ hybridization were performed to localize NOX4 mRNA on 
mouse lung sections. 
 
 
 
 
Figure 10. Localization of NOX4 in mouse lung sections by in situ hybridization (ISH) 
 
a, b) Hybridization of the NOX4 antisense probe to mouse lung cryosections (green fluorescence). c, d) The 
same sections stained with a Cy3-labelled antibody directed against -smooth muscle actin (SMA, red 
fluorescence). e, f) Overlay of the images a and b depicting predominant co-localisation of NOX4 transcripts 
with SMA in the smooth muscle cell layer of the pulmonary artery (yellow fluorescence). B: bronchus, PA: 
pulmonary artery.  
 
The transcripts of NOX4 were localized in different cell types with prominent presence in the 
vessel media, as confirmed by its co-localisation with -smooth muscle actin (Fig. 10). In 
addition, the NOX4 merged staining showed that the transcripts were present in non-vascular 
compartments comprising of bronchial smooth muscle cells and alveolar type II cells. In this 
regard, NOX4 transcripts were detected in isolated alveolar type II cells from mouse (data not 
shown). 
 
5.1.4 Hypoxic regulation of NOX4 at protein level in mice lung  
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In addition to the observations that NOX4 mRNA was predominantly present in the vessel 
media, the presence of NOX4 protein in the vessels was further confirmed by immunostaining 
on mouse lung sections (Fig. 11)1. 
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c
Nox4
d
merge
e  
 
 
 
 1 Figure 11. NOX4 immunostaining comparing mice maintained either under normoxic (21% O2) or 
hypoxic (10% O2) conditions 
a) In the normoxic mice, the majority of vessels displayed very less NOX4 immunoreactivity (arrows) . b) Under 
hypoxia, the majority of vessels were immunoreactive for NOX4 (arrows). Note the slight autofluorescent 
bronchial epithelium (arrowhead). c, d) Labeling of NOX4 and -smooth muscle actin (SMA), confocal image. 
A subgroup of SMA-immunoreactive cells in the vessel wall was also NOX4 immunoreactive (arrows), as 
evident for the merged images c and d (e). f) Percentage of NOX4 immunoreactive vessels in normoxic mice and 
mice exposed to chronic hypoxia (10% O2) for up to 21 days. The mean value for every animal is shown in the 
box plot. g) Mean diameter of NOX4 immunoreactive vessels during development of hypoxia-induced 
pulmonary hypertension. The mean value for every animal is shown in the box plot; n = number of animals 
examined per experimental condition, *p<0.05; boxes: percentiles 25 and 75, black bar: median, whiskers: 
percentiles 0 and 100, O = value is more than 1.5 lengths of a box away from the edge of a box. 
                                                 
1 Imaging and quantification was performed and data were provided by Dr. Peter König. 
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NOX4-immunoreactivity was observed in a subset of cells of the medial wall of the 
pulmonary artery, as well as in some smaller pulmonary arteries (Fig. 11 a-e). After exposure 
to chronic hypoxia, the number of NOX4 positive vessels was significantly increased after 
three days of exposure to hypoxia (Fig. 11 f). The number of small NOX4 immunopositive 
vessels was also significantly increased after 7 and 21 days of hypoxia (Fig. 11 g), indicating 
that the newly-formed and muscularized smaller vessels were also NOX4-immunoreactive.  
5.1.5 Sub-cellular localisation of NOX4 in isolated mouse pulmonary arterial smooth 
muscle cells and its regulation in hypoxia 
 
At the sub-cellular level, NOX4 protein exhibited a predominantly perinuclear localisation in 
mouse PASMC (Fig. 12 a, b). The intensity of staining increased after 48 h of hypoxic 
incubation as compared to normoxic control (Fig. 12 c, d). The perinuclear localisation of 
NOX4 reflects the presence of NOX4 protein in the endoplasmic reticulum. 
 
 
 
Figure 12. Cellular NOX4 localisation in mouse pulmonary arterial smooth muscle cells by 
immunofluorescence.  
The NOX4 immunostaining of isolated murine pulmonary arterial smooth muscle cells revealed a perinuclear 
localisation, and a slight increase of NOX4 immunoreactivity when PASMC were incubated for 48 h under 
hypoxic conditions, compared to cells incubated under normoxic conditions. a) Murine PASMC stained with an 
anti-NOX4 antibody and b) with an additional nuclear marker (Hoechst). c) NOX4 immunoreactivity of murine 
PASMC after 48 h under normoxic (21% O2), compared to d) hypoxic (1% O2), conditions. 
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5.1.6 Immunostaining of NOX4 and NOX2 on human lung sections 
 
Histological staining of human lung sections from healthy donors and from patients with 
idiopathic pulmonary arterial hypertension (IPAH) confirmed NOX4 expression in the vessel 
media of the pulmonary arteries (Fig. 13 a-d). In contrast to NOX4, NOX2 was primarily 
expressed in the endothelial layer of the human pulmonary arteries (Fig. 13 e, f).  
 
 
 
Figure 13. Localisation of NOX4 and NOX2 in human donor and IPAH lungs. 
The NOX4 immunostaining of human donor (a, c) and IPAH (b, d) lung sections revealed a localisation of 
NOX4 predominantly in the medial layer of pulmonary arteries. In contrast NOX2 immunostaining was 
localized mainly in the endothelium of human donor (e) and IPAH (f) lung sections (arrows).  
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5.1.7 Regulation of NOX4 in idiopathic pulmonary arterial hypertension (IPAH)  
 
Western blot analysis of lung homogenate from IPAH patients compared to healthy donor 
lungs revealed a significant (p<0.001) 2.5-fold higher NOX4 protein level in IPAH patients 
(Fig. 14). 
 
 
Figure 14. Detection of NOX4 by western blot in human donor and IPAH lungs  
a) Western blots of human IPAH lungs (n=4) compared to healthy donor lungs (n=6) revealed a 2.5-fold up-
regulation of NOX4 expression in human IPAH lungs (specific band at 64 kDa). The NOX4 was normalized to 
-actin. * indicates significant difference as compared to donor lungs. 
5.1.8 Effect of hypoxia on NOX4 mRNA levels in human PASMC 
 
In addition, NOX4 transcripts quantified by real-time PCR were increased in human donor 
PASMC from passage 3 exposed to hypoxia for 24 h, compared to normoxic controls (Fig. 
15).  
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Figure 15. Hypoxia induced up-regulation of NOX4 in isolated human pulmonary artery smooth muscle 
cells. Isolated human pulmonary arterial smooth muscle cells (PASMC) were maintained under hypoxic (1% O2) 
or normoxic (21% O2) conditions for 24 h. The NOX4 mRNA levels were quantified by real-time PCR and 
standardized to 2-microglobulin mRNA levels. A significant increase in NOX4 mRNA was observed after 24 h 
of hypoxic versus normoxic treatment (*). Data are derived from duplicate measurement of n=3 independent cell 
preparations. 
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5.1.9 Role of NOX4 in the proliferation of human PASMC 
 
To investigate a possible functional role of NOX4 for cell proliferation, it was demonstrated 
that siRNA directed against human NOX4 significantly reduced the NOX4 mRNA level (Fig. 
16 a) and suppressed the proliferation of human passage 3 PASMC (Fig. 16 b) correlating 
with a decrease of reactive oxygen species (ROS) generation (Fig. 16 c).  
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Figure 16. Suppression of human pulmonary arterial smooth muscle cell proliferation and reactive oxygen 
species generation by siRNA directed against NOX4 
a) Quantification of NOX4 in siNOX4 transfected human PASMC showing significant down-regulation of 
NOX4 as compared to scrambled control. b) The normoxic proliferation of PASMC was investigated using 3H-
thymidine. c) Reactive oxygen species quantification by dihydroethidium fluorescence in scrambled and NOX4 
siRNA transfected human PASMC. *indicate significant differences between NOX4 siRNA and scrambled 
siRNA experiments. Data are derived from duplicate cell isolations of n=5 independent lungs. cpm, counts per 
minute. 
 
5.2 Effect of NOX4 on KDR channel function in rat PASMC under chronic hypoxia 
 
5.2.1 Co-localisation of NOX4 with KDR channels in the rat lung sections  
 
Reduced function and expression of KDR channels in chronic hypoxia is considered as an 
important key event in the pathogenesis of hypoxia induced pulmonary hypertension. 
Previous reports have indicated that the Kv channel gating can be affected by the oxidative 
modification at the N-terminal cytoplasmic inactivation domain 112-114. Despite the presence 
of both NOX2 and NOX4 in the pulmonary vasculature, the fact that only NOX4 is up-
regulated under chronic hypoxia, leads to the question about a functional link between NOX4 
derived oxidative stress and KDR channels. The realationship between NOX4 and KDR 
channels was investigated in isolated rat PASMC because of the technical difficulty in 
handling mouse PASMC and in getting enough material for expression analysis. 
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To explore a functional link between NOX4 and KDR channels, it was first examined if NOX4 
and KDR channel are co-localised under in vivo.  
 
 
Figure 17. Co-localisation of NOX4 with Kv1.5 and Kv2.1 channels on rat lung sections. (a and b) 
Immunostaining on rat lung sections using Kv1.5 antibody (red) and NOX4 antibody (green). (d and e) 
Immunostaining on rat lung sections using Kv2.1 (red) and NOX4 antibody (green). (c and f) an overlay of 
images a and d depicting the co-localisation of  Kv1.5 and Kv2.1 channels with NOX4. B: Bronchus; V: Vessel. 
 
Immmunofluorescence on rat lung sections revealed a strong co-localisation of NOX4 with 
Kv1.5 and Kv2.1 channels in the vessels, bronchus and alveolar space (Fig. 17).  
 
 
Figure 18. Co-localisation of NOX4 with Kv1.5 and Kv2.1 channels in isolated rat PASMC. (a and b) 
Immunostaining on rat PASMC using a directly labelled NOX4 antibody (green) and Kv2.1 antibody (red). (c 
and d) Immunostaining on rat PASMC using a directly labelled NOX4 antibody (green) and Kv1.5 antibody 
(red). (c and f) An overlay of images in a and d depicting colocalisation of NOX4 wit Kv2.1 and Kv1.5 channels.  
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The co-localisation of NOX4 with Kv1.5 and Kv2.1 channels was further confirmed in 
isolated rat PASMC (Fig. 18). NOX4 showed a strong co-localisation with Kv1.5 and Kv2.1 
channels on plasma membrane and in perinuclear space.  
5.2.2 Effect of chronic hypoxia on the delayed rectifier K+ current 
 
The whole cell patch clamp technique was used to measure the delayed rectifier K+ current 
(KDR) in rat PASMC exposed for 48 h in hypoxia (1% O2). Membrane currents were recorded 
in response to the voltage steps from -70 mV to 90 mV in a 20 mV increment from a holding 
potential of –50 mV. When the current densities (whole cell currents divided by its 
capacitance) were plotted against Vm, it was observed that hypoxic treatment significantly 
reduced the current density of delayed rectifier K+ channels of rat PASMC at all positive Vm 
(Fig. 19). 
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Figure 19. Chronic hypoxia treatment decreased the whole cell delayed rectifier K+ current of rat 
PASMC.  
Rat PASMC were exposed for 48 h in hypoxia (1% O2) and whole cell delayed rectifier K+ currents were 
measured from the voltage steps of -70 mV to 90 mV in a 20 mV increment from a holding potential of -50 mV. 
At -50 mV greater than 90% of KA current was not available so that mainly the current from delayed rectifier K+ 
channels was recorded. An I-V plot showed a significant reduction in the KDR current density in rat PASMC 
exposed for 48 h in hypoxia in all positive Vm. n= number of the cells. * p<0.05 compared to normoxic cells. 
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5.2.3 Effect of apocynin on the delayed rectifier K+ current in rat PASMC 
 
Whole cell patch clamp recordings revealed that apocynin treatment significantly increased 
the KDR current density of rat PASMC by approximately 2.7 fold at 90 mV compared to 
DMSO (solvent control) treated control cells under hypoxic conditions (Fig. 20 b, Table 5). 
The KDR current density at 90 mV on the DMSO treated hypoxic cells was 15.2±1.8 pA/pF, 
which was increased to 41.4±8.7 pA/pF (p<0.05) with apocynin treatment. 
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Figure 20. Treatment of rat PASMC with 0.5mM apocynin significantly increased the whole cell KDR 
current as compared to control cells. 
a) Representative recordings of whole cell KDR currents showing an increase in KDR currents in response to 0.5 
mM apocynin treatment under hypoxic conditions. Whole cell KDR currents were collected from -70 mV to 90 
mV voltage steps from a holding potential of -50 mV in a 20 mV increment step. b) I-V curve expressed as the 
whole cell KDR current density against Vm. A significant increase in KDR current density was observed under 
hypoxic conditions from treatment with 0.5 mM apocynin as compared to DMSO treatment. c) Hypoxia 
significantly decreased the KDR current density in DMSO treated hypoxic cells compared to DMSO treated 
normoxic cells. n=number of the cells from two rats. * p<0.05 compared to DMSO treated hypoxic cells. 
+p<0.05 compared to DMSO treated normoxic cells. 
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The density of KDR current was significantly reduced in DMSO treated hypoxic rat PASMC 
as compared to DMSO treated normoxic cells (Fig. 20 c) (Table 5). 
 
 
Table 5:  Comparison of KDR current densities of rat PASMC under normoxic and hypoxic conditions 
with apocynin treatment and solvent control (DMSO) 
 
 Vm  
(mV) 
Normoxia-72 h 
DMSO 
 (n=10) pA/pF 
Hypoxia-72 h,   
DMSO 
(n=11) pA/pF 
Hypoxia-72 h 
0.5mM Apocynin 
 (n=8 ) pA/pF 
-70 -0,3±0,4 -0.1±0.1 0.7±0.3 
-50 -0,7±0.2 0.0±0.08 0.0±0.2 
-30 0.0±0.5 0.0±0.1 -0.2±0.4 
-10 3.6±1.2 0.9±0.4 0.8±0.5 
10 13.4±2.7 1.7±0.9 5.7±1.7 
30 25.1±4.2 3.3±1.3+ 12.2±3.7 
50 37.8±6.1 5.7±1.7+ 20.3±5.5 
70 49.0±7.3 9.6±1.7+ 30.0±6.6* 
90 65.8±8.4 15.2±1.8+ 41.4±8.7* 
 
 
Values are given as Mean ± SEM (standard error of mean) 
* p<0.05 compared to DMSO treated hypoxic cells 
+p<0.05 compared to DMSO treated normoxic cells  
 
 
 
 
 
5.2.4 Increased current density of Kv2.1 and Kv1.5 channels after apocynin treatment  
 
The currents specific to Kv2.1 and Kv1.5 channels were dissected out from the whole cell 
KDR currents using the antibodies specific to Kv2.1 and Kv1.5 channels 115;116. The membrane 
currents from normoxic rat PASMC were recorded at voltage steps from -70 mV to 90 mV 
with Kv1.5 and Kv2.1 antibodies in the intracellular pipette solution (Fig. 21 a). 
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 Figure 21. Time course of inhibition of KDR current with Kv1.5 and Kv2.1 antibodies in the intracellular 
pipette solution and I-V curve expressed as current densities against Vm.  
a) Both antibodies at dilution of 1:100 were dissolved in the intracellular pipette solution. T-0 represents the 
recording made immediately after the membrane rupture. Further time points represent the time taken by the 
antibodies to diffuse in to the cell from the pipette pore to block the Kv1.5 and Kv2.1 specific current. I-V curve 
revealed a 55% inhibition of KDR current density after 22 min of dialysis with Kv2.1 and Kv1.5 antibodies. b) No 
run down was observed of the whole cell KDR current even after 25 min of the establishment of the whole cell 
configuration in the absence of antibodies in the intracellular solution.  
 
The initial recording of the whole cell KDR current was made immediately after the 
establishment of a whole cell configuration and is represented by T-0. Further recording at 
different time intervals revealed a gradual decrease in the KDR current density with increasing 
time. A 55% inhibition of KDR current was observed after 22 min of the break in which could 
indirectly represent the percentage of Kv1.5 and Kv2.1 specific current in the whole cell KDR 
current (Fig. 21 a). No effect of run down on the KDR current was observed in the normoxic 
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rat PASMC even after 25 min in to the whole cell configuration in the absence of antibodies 
(Fig. 21 b). 
Interestingly, the inhibition of KDR current by Kv1.5 and Kv2.1 antibodies was observed only 
in the hypoxic group of PASMC treated with apocynin, no inhibition of KDR current was 
observed in the control DMSO treated hypoxic rat PASMC (Fig. 22 a). Moreover, the current 
density was significantly higher even after antibody blockage in apocynin treated hypoxic 
PASMC compared to DMSO treated hypoxic control (Fig. 22 a). 
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Figure 22. Effect of inhibition on the whole cell KDR currents by Kv1.5 and Kv2.1 antibodies in DMSO 
treated and apocynin treated hypoxic rat PASMC at different Vm. 
a) I-V curve revealed an inhibition of the KDR current by Kv2.1 and Kv1.5 specific antibodies in the apocynin 
treated rat PASMC whereas no inhibition was observed in the DMSO treated hypoxic rat PASMC. b) Apocynin 
treatment under hypoxia increased the current density of Kv2.1 and Kv1.5 channels on rat PASMC at all positive 
Vm. n= number of the cells from two rats. * indicates p<0.05 compared to DMSO treated hypoxic cells after 
antibody dialysis. * p<0.05 compared to DMSO hypoxic cells. Ab; antibody. 
 
The difference in currents before and after antibody blockage revealed a specific increase in 
the current density of Kv1.5 and Kv2.1 channels on rat PASMC treated with apocynin under 
hypoxia at all positive Vm  (Fig. 22 b). 
5.2.5 Treatment with NOX4 siRNA in rat PASMC increased the KDR current density  
 
To investigate the role of NOX4 in the regulation of hypoxia sensitive KDR channels, rat 
PASMC were transfected with the NOX4 specific siRNA and were kept under normoxic 
conditions for three days to lower down the level of NOX4 protein. After this period, cells 
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were transferred to hypoxic conditions for 48 h and normoxic cells stayed under normoxia up 
to the same time period. 
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Figure 23. Treatment of rat PASMC with siNOX4 increased the KDR current density under hypoxic 
conditions. a) Representative recordings of KDR current revealed a significant increase on siNOX4 treatment 
under hypoxia. b) I-V curves revealed a significant 5 fold increase in the KDR current density at all positive Vm on 
rat PASMC transfected with NOX4 siRNA as compared to scrambled siRNA treated cells under hypoxic 
conditions. c) Hypoxia significantly decreased the KDR current density of scr siRNA treated hypoxic PASMC as 
compared to scrambled siRNA treated normoxic cells. d) Immunoblot revealed that chronic hypoxia increased 
NOX4 protein level in PASMC and siNOX4 treatment decreased the NOX4 protein. n=number of the cells from 
two rats. * p<0.05 compared to scrambled siRNA treated hypoxic cells. +p<0.05 compared to scrambled siRNA 
treated normoxic cells. 
 
I-V curve revealed that the KDR current increased significantly by 5 fold in the rat PASMC 
transfected with NOX4 siRNA at Vm of 90 mV as compared with scrambled (Scr) siRNA 
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treated cells under hypoxic conditions (Fig. 23 b, Table 6). The mean KDR current density of 
scrambled siRNA treated hypoxic rat PASMC was 19.9±5.4 pA/pF (n=10) at Vm of 90 mV 
which increased up to 105.9±30.2 pA/pF (n=12, p<0.05) on siNOX4 treatment (Table 6). 
Hypoxia significantly decreased the KDR current density at all positive Vm on the scrambled 
siRNA treated hypoxic cells as compared to scrambled siRNA treated normoxic cells (Fig. 23 
c, Table 6). Similar to up-regulation of NOX4 in the mouse and human PASMC, an up-
regulation of NOX4 protein was also observed in the isolated rat PASMC exposed to 48 h of 
hypoxia and treatment with NOX4 siRNA decreased the NOX4 protein levels (Fig. 23 d). 
 
Table 6:  Comparison of KDR current density of rat PASMC after treatment with scrambled and NOX4 
siRNA under normoxic and hypoxic conditions 
    
 Vm 
(mV) 
Scr 
Normoxia- 48 h 
(n=9) (pA/pF) 
Scr 
Hypoxia-48 h 
(n=10) (pA/pF) 
siNOX4 
Hypoxia-48 h   
( n=12) (pA/pF) 
 
-70 0.4±0.3 -0.6±0.2 0.0±0.5 
-50 -0.2±0.2 0.0±0.1 -0.3±0.5 
-30 -0.8±0.7 0.4±0.1 3.7±3.0 
-10 3.0±1.9 0.8±0.3 26.1±11.2 
10 12.5±5.1 1.5±0.4 45.6±17.4* 
30 24.7±9.3 2.7±0.6+ 63.1±22.6* 
50 37.3±12.8 5.4±1.1+ 77.5±26.1* 
70 50.6±15.9 11.0±2.7+ 91.9±29.4* 
90 63.4±18.5 19.9±5.4+ 105.9±30.2* 
 
Values are given as Mean ± SEM (standard error of mean) 
+ p<0.05 compared to Scr normoxic cells  
 *p<0.05 compared to Scr hypoxic cells  
 
 
 
5.2.6 NOX4 siRNA affected the activation kinetics of KDR current under chronic 
hypoxia 
 
The treatment of rat PASMC with NOX4 siRNA under chronic hypoxia resulted in a 
significant hyperpolarising shift of the voltage dependent activation and a reduction in the 
slope factor K (Fig. 24 a). The steady state activation kinetics was fitted to the Boltzman 
equation G/Gmax=1/(1+e-(V-V1/2)/K)n. Whereas V1/2 is the half maximal activation potential of 
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KDR current and K is the slope factor. The Boltzman distribution of scr siRNA treated hypoxic 
cells had a V1/2 = 11.43 mV (n=5) which was shifted to hyperpolarising direction of V1/2 = -
9.89 mV (n=9) by siNOX4 treatment under chronic hypoxia. This hyperpolarising shift was 
accompanied by a decrease in the value of slope factor K from 15.80 in scr siRNA treated 
cells to 12.77 in NOX4 siRNA treated cells under hypoxia.  
 
 
-60 -40 -20 0 20 40 60 80 100
0.0
0.2
0.4
0.6
0.8
1.0
G
/G
m
ax
Vm (mV)
V1/2= -9.89 
K=12.779 V1/2= 11.43
K=15.80
Scr Hypoxia-48 h, n=5
siNOX4 Hypoxia-48 h, n=9
*
*
G
/G
m
ax
 
 
Figure 24. Conductance voltage relationship of KDR current in rat PASMC transfected with NOX4 siRNA 
under chronic hypoxia.  The conductance was calculated from the peak current amplitude divided by the K+ ion 
driving force calculated from the Nernst equation and normalised with the maximal conductance in a given 
series of voltages. NOX4 siRNA significantly affected the half maximal activation potential (V1/2) of KDR current 
and shifted it towards more hyperpolarising potentials accompanied by a decrease in the slope factor (K). 
 
5.3 Effect of NOX4 on calcium influx and ROS production in rat PASMC under 
chronic hypoxia
5.3.1 Treatment of rat PASMC with apocynin reduced the endothelin-1 (ET-1) 
stimulated calcium influx under chronic hypoxia 
 
Further investigations were performed to explore the possibility of NADPH oxidase derived 
ROS production in regulation of calcium influx in rat PASMC using apocynin. The treatment 
of rat PASMC with 0.5 and 2 mM apocynin under hypoxia resulted in the disappearance of 
the transient calcium peak induced by endothelin-1 (ET-1) and delayed the sustained increase 
in calcium by approximately 200 s compared to DMSO treated hypoxic cells (Fig. 25). The 
overall ET-1 induced calcium influx was much reduced in the apocynin treated hypoxic 
PASMC compared to DMSO (solvent) control. 
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Figure 25. Measurement of intracellular calcium concentration in rat PASMC treated with apocynin 
under chronic hypoxia. Pharmacological inhibition of NADPH oxidases with apocynin resulted in reduced 
calcium influx under hypoxic conditions. Calcium measurement was done using the calcium sensitive dye Fura-
2. The PASMC were loaded with Fura-2 for 1 h at 37 oC. ET-1 (20 nM) was applied at a time point of 60s.  
Apocynin treatment reduced the ET-1 stimulated calcium influx in rat PASMC compared to the DMSO control 
under chronic hypoxia. 
 
 
5.3.2 NOX4 siRNA reduced the the endothelin-1 (ET-1) stimulated calcium influx 
under normoxia and abolished it completely under chronic hypoxia 
  
The role of NADPH oxidase derived ROS production in regulation of calcium influx was 
further strengthened by the use of NOX4 specific siRNA. The treatment of rat PASMC with 
two different sequences of NOX4 specific siRNA resulted in reduced ET-1 stimulated 
calcium influx under normoxic conditions compared to scrambled control and complete 
disappearance of calcium influx under hypoxia (Fig. 26 a and b). Although ET-1 primed 
calcium influx was much lower in scrambled hypoxic cells compared to scrambled normoxic 
cells, the basal calcium levels (before ET-1 stimulation) were higher (Fig. 26 a and b). Both 
sequences of NOX4 siRNA abolished the transient calcium peak induced by ET-1 and 
delayed the overall calcium influx under normoxia (Fig. 26 a). Sequence-2 of NOX4 siRNA 
was more effective than sequence-1 in delaying the sustained calcium increase and reducing 
the overall calcium influx under normoxia (Fig. 26 a), whereas under hypoxia both sequences 
abolished the calcium influx while sequence-2 being marginally more effective than 
sequence-1 (Fig. 26 b).  
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Figure 26. Measurement of intracellular calcium in rat PASMC treated with NOX4 siRNA under 
normoxic and hypoxic conditions. a) NOX4 siRNA reduced the endothelin-1 (ET-1) primed calcium influx in 
rat PASMC under normoxic conditions. ET-1 (20 nM) was applied at a time point of 60 s.  The PASMC were 
loaded with Fura-2 for 1 h at 37 oC.  Two different sequences of NOX4 siRNA were used to reproduce the 
effect. Sequence 2 of NOX4 siRNA was used previously in electrophysiology. b) NOX4 siRNA completely 
abolished the ET-1 stimulated calcium influx under hypoxia compared to scrambled siRNA control. The basal 
calcium level was higher in scrambled siRNA treated hypoxic cells compared to scrambled normoxic control. 
The data is averaged from three independent experiments on the cells isolated from two rats. 
 
5.3.3 Increased ROS production and its attenuation with NOX4 siRNA in rat PASMC 
under chronic hypoxia  
 
To reproduce the previously reported effect of NOX4 on ROS production in human PASMC 
(Fig. 16), the ROS was measured in rat PASMC using another oxidation sensitive dye i.e. 
dichloro flourescein diacetate (DCF-DA). An increased ROS production was observed in 
PASMC exposed to 48 h and 72 h of hypoxia and treatment with NOX4 siRNA attenuated 
this increase (Fig. 27 a, b). In addition, ET-1 stimulated ROS production was significantly 
reduced in PASMC treated with NOX4 siRNA (Fig. 27 c). This finding can be correlated with 
the reduced calcium influx on ET-1 stimulation in siNOX4 treated PASMC (Fig. 27 c and 
Fig. 26). 
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Figure 27. ROS measurement in rat PASMC treated with NOX4 siRNA under chronic hypoxia. 
a) ROS was measured using oxidation sensitive dye DCF-DA in rat PASMC exposed to chronic hypoxia. A 
significantly increased ROS production was observed in PASMC under chronic hypoxia (72 h) compared to 
normoxic control. b) The bar graph shows the basal ROS level in rat PASMC without ET-1 stimulation. 
scrambled siRNA treated hypoxic (48 h) cells were found to produce significantly more ROS compared to 
normoxic scrambled siRNA control and treatment with NOX4 siRNA attenuated the ROS increase in hypoxic 
PASMC. c) The bar graph depicts the ET-1 stimulated increase in ROS in rat PASMC treated with NOX4 
siRNA exposed to chronic hypoxia. ET-1 stimulated ROS production was significantly reduced in rat PASMC 
treated with NOX4 siRNA. The data is averaged from three independent experiments from the cells isolated 
from three rats. * p<0.05. 
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6  DISCUSSION 
 
  
Acute alveolar hypoxia induces constriction of pulmonary artery vessels, which is an essential 
mechanism to adapt perfusion to ventilation, and thus to optimise pulmonary gas exchange 
5;49. Previous reports from our laboratory have suggested that p47phox knockout mice exhibited 
reduced acute HPV, while vasoconstriction elicited by the thromboxane mimetic U46619 was 
not affected 49. In contrast to the beneficial effects of HPV for regional alveolar hypoxia, 
chronic alveolar hypoxia induces remodeling of the pulmonary vasculature, characterised by 
hypertrophy of the vessel media, and thus a narrowing of the vascular lumen. This leads to an 
increased pulmonary vascular resistance, pulmonary hypertension and may result in right 
heart failure 122.  
The role of oxidative stress in hypertrophy of vascular media has been widely recognised for 
some time and NADPH oxidase-generated ROS has been demonstrated in a mouse model to 
contribute to vascular hypertrophy 5;94;117-119. However, little is known regarding the 
downstream target of NADPH oxidase derived ROS which induces vascular hypertrophy. The 
current thesis demonstrated the regulation of NADPH oxidases and their ability to regulate 
KDR channels and calcium influx under chronic hypoxia via ROS production. 
6.1 Screening of NADPH oxidases for their potential role in the development of hypoxia 
induced pulmonary hypertension 
 
With respect to the lung, relatively few reports of the expression and regulation of the recently 
identified new vascular NADPH oxidase subunits exist. Hoidal and coworkers 119 have 
demonstrated that NOX4 is the predominant homolog in human airway and pulmonary artery 
smooth muscle cells 123. In addition Hohler et al. identified a low output NADPH oxidase in 
pulmonary artery endothelial cells 124.  
 
Thus, in screening for the hypoxic regulation of NADPH oxidases in the lung homogenate of 
the mice exposed to three days and three weeks of hypoxia, a significant up-regulation of 
NOX4 was observed by real time PCR. In contrast, NOX1 and NOX2 did not exhibit any 
significant regulation and the other subunits were downregulated. Investigations of the 
recently identified new isoforms of phagocytic NADPH oxidase subunits in the lung is of 
interest, since NADPH oxidases have been proposed as possible pulmonary oxygen sensors 
5;119. With respect to an additional role for non-phagocytic NADPH oxidase subunits in the 
pathophysiology of hypoxia-induced pulmonary hypertension, the present study focused on 
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NOX4, because: 1) NOX4 is the only non-phagocytic NADPH oxidase subunit prominently 
expressed in the media of mouse pulmonary arteries which has been suggested as the main 
site of oxygen sensing, 2) NOX4 was significantly up-regulated in chronic hypoxia in 
homogenised mouse lung tissue, 3) NOX4 acts as an oxygen sensor to regulate TASK-1 
activity in HEK 293 cells 125 and 4) it was recently suggested that this subunit may contribute 
to pathophysiological changes in the systemic vasculature and in the pulmonary arteries 31;123. 
In two recent investigations, a prominent expression of NOX1 and NOX4 was demonstrated 
in colon and kidney, respectively, by northern blotting 34;126. In a previous study, an NADPH 
oxidase homolog NOX1 was identified in homogenised rabbit lungs, and in PASMC 127. 
Recently, NOX4 was suggested to be the predominant NOX2-homolog in human airway and 
pulmonary arterial smooth muscle cells 119;123 and Liu and colleagues provided evidence that 
the phagocytic NADPH oxidase subunit NOX2 plays an important role in the development of 
hypoxia-induced pulmonary hypertension 99. With respect to the current findings Suliman and 
coworkers have also supported a possible role for NOX4 in the context of oxygen sensing in 
the mouse kidney, demonstrating induced expression of the renal-specific NADPH oxidase 
(NOX4) under hypoxic conditions 128. The selective up-regulation of NOX4 in chronic 
hypoxic mouse lung may indicate its importance in vascular remodeling process. 
6.2 Comparison of hypoxic regulation of NOX2 and NOX4 in the pulmonary vasculature 
 
Remodeling of small pulmonary arteries is considered to be the major cause of the increase in 
vascular resistance occurring during chronic hypoxia, therefore hypoxia-dependent regulation 
of NOX4 and NOX2 mRNA was investigated in the vessels of the murine pulmonary 
vasculature, since NOX2 has been suggested to play a pivotal role in the development of 
chronic hypoxia-induced pulmonary hypertension by Liu et al. 99. Real time PCR analysis 
revealed that NOX4, in contrast to NOX2, is elevated in the pulmonary vasculature by 
chronic hypoxia: up-regulation of NOX4 but not of NOX2 occurred in the pulmonary arteries 
within 21 days of exposure to hypoxia, as demonstrated by quantitative PCR of 
microdissected vessels. Moreover, in situ hybridization revealed that NOX4 transcripts were 
localized to the pulmonary artery smooth muscle layer. The hypoxia-dependent increase in 
NOX4 expression levels in the pulmonary vasculature correlated well with the development 
of pulmonary hypertension 129 and was corroborated further at the protein level: 1) NOX4-
immunoreactivity was detected in the pulmonary vasculature by immunostaining, and 2) the 
percentage of NOX4 immunoreactive vessels was strongly increased by chronic alveolar 
hypoxia with an increase in the number of NOX4-positive small vessels. The up-regulation at 
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the protein level preceded the regulation on the mRNA level. This suggests that NOX4 can be 
regulated on both the mRNA and the protein level. The differential regulation of NOX4 and 
NOX2 can also be due to their different activation mechanisms. While the activation of 
NOX1, NOX2 and NOX3 is dependent on the presence of additional cytosolic subunits such 
as p47phox and p67phox (for NOX2 activation) or NOXO1 and NOXA1 (for NOX1 activation), 
the activation of NOX4 is independent of such cytosolic subunits 130. The co-expression 
studies done by Kawahara et al. have demonstrated that NOX4 can generate ROS 
independent of the cytosolic subunits 130. The Real time PCR analysis of lung homogenates 
from mice exposed to hypoxia revealed a selective up-regulation of NOX4 and down-
regulation of the other cytosolic subunits essential for NOX1 and NOX2 activation. In this 
regard, the up-regulation of NOX4 can be viewed as significantly more important in the state 
of chronic hypoxia compared to NOX2, which is more dependent on the presence of cytosolic 
subunits for its activation. At the subcellular level, the perinuclear localisation of NOX4 in the 
PASMC supports the notion of the presence of the protein in the endoplasmic reticulum (ER), 
as recently demonstrated in microvascular endothelial cells by Görlach and coworkers 131. The 
presence of NOX4 in the ER further suggests an important role of NOX4 in maintaining the 
redox potential and Ca2+-homeostasis in PASMC 132. 
 
The findings of Liu et al. that NOX2 is essential for development of hypoxia-induced 
pulmonary hypertension, together with the fact that we as well as Liu et al. were unable to 
detect regulation of NOX2 in pulmonary arteries by hypoxia, are suggestive that NOX2 and 
NOX4 may play a differential role in the development of hypoxia-induced pulmonary 
hypertension. Hypothetically, endothelial ROS generation by NOX2 may stimulate NOX4 up-
regulation in the vessel media, which would be important for hypoxia-dependent PASMC 
proliferation. In line with this argumentation is the detection primarily of NOX2 in pulmonary 
vascular endothelial cells in the current study, as well as two recent reports demonstrating a 
ROS-dependent up-regulation of NOX4 in cardiac cells 133;134.  
6.3 Role of NOX4 in idiopathic pulmonary arterial hypertension (IPAH) and regulation of 
human PASMC proliferation by ROS generation 
 
A possible role of NOX4 in the pathogenesis of pulmonary hypertension in general was 
supported by the fact that NOX4 is up-regulated in the vessel media of lung sections from 
patients with IPAH that underwent lung transplantation, compared to healthy donor lungs. 
The fact that NOX4 is up-regulated in the vessel media in both hypoxia-induced pulmonary 
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hypertension and in human IPAH may be explained by distinct or common regulators of 
NOX4. With regard to the latter it has been shown that TGF- can upregulate NOX4 in 
human PASMC 123, that hypoxia can increase TGF- in PASMC 135, and that interference 
with TGF- blocks hypoxia-induced vascular remodeling 136. Interestingly, it has been shown 
that TGF- can vice versa be regulated by ROS 137. In addition, it appears that NOX4 
dependent regulation of human PASMC proliferation is via ROS generation as silencing of 
NOX4 reduced human PASMC proliferation and ROS production. These findings are in 
agreement with the recent work of Sturrock et al. who also observed up-regulation of NOX4 
by TGF- and reduced proliferation of human PASMC on silencing of NOX4 123. Thus, 
hypoxia-induced and human IPAH may share some common pathophysiological mechanisms 
with regard to NOX4. 
6.4 NOX4 mediated regulation of KDR channels Kv1.5 and Kv2.1 at the functional level 
(electrophysiology) 
 
The KDR channels belong to a subfamily of voltage-gated K+ channels and are responsible for 
maintaining the membrane potential of resistance PASMC due to their high abundance in the 
lower segments of pulmonary vasculature 63;138 . Many reports have documented that vascular 
remodeling in chronic hypoxia induced pulmonary hypertension is due to reduced KDR 
channel function and increased calcium influx in PASMC 59. The selective inhibition of KDR 
channels in the pulmonary vasculature has attracted much attention with the aim to identify 
the underlying mechanism behind this process. The role of oxidative stress has recently been 
shown by several reports in the regulation of Kv channels by oxidative modification at key 
cysteine residues 139 112. There are several sources of oxidative stress in the cell including 
mitochondria, xanthine oxidases, cyclooxygenase, uncoupled nitric oxide synthase and 
NADPH oxidases. Of these various sources, NADPH oxidases have recently gained the focus 
of main ROS producing enzymes in the vessels 140. Previous reports have indicated that 
gp91phox (NOX2) at least is not responsible for hypoxia mediated inhibition of Kv current in 
the mouse lung 141. However, there is no evidence yet which suggests the involvement of 
NOX4-derived ROS in the regulation of KDR channels in the lung vasculature. Thus, to 
delineate the downstream signaling pathway of NOX4, two hypoxia-sensitive members of  the 
KDR subfamily, Kv1.5 and Kv2.1, were investigated since: 1) Kv2.1 channel has been shown 
to be an important determinant in maintaining the resting Em in resistance PASMC and 
application of an antibody against Kv2.1 in electrophysiological preparation abolished further 
hypoxic inhibition of IKv in PASMC 115;116, 2) both of these channels are abundantly expressed 
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in resistance PASMC at protein and mRNA level 88, 3) the expression of both channels is 
down-regulated in PASMC under chronic hypoxia at the mRNA and protein levels 86;87, 4) 
Kv1.5 knockout mice exhibit impaired hypoxic pulmonary vasoconstriction 67 and 5) down-
regulation of Kv channels in hypoxia has been linked to decreased apoptosis and increased 
proliferation due to intracellular inhibition of caspases 90;142.  
 
Therefore, in an attempt to investigate a functional relationship between NOX4 and KDR 
channels, a strong co-localisation of NOX4 with Kv1.5 and Kv2.1 channels on both rat lung 
sections and isolated PASMC was observed. The NOX4 mediated regulation of KDR currents 
in rat PASMC was corroborated at the functional level by electrophysiology (whole cell 
configuration). The treatment of rat PASMC with 0.5 mM apocynin under hypoxia resulted in 
a significant increase in the whole cell KDR current. When antibodies specific for Kv1.5 and 
Kv2.1 channels were added in the intracellular pipette solution, a significant 55% inhibition of 
the whole cell KDR current was observed, indicating that both channels conduct a large portion 
of the KDR current. Similar observations have been noted in previous reports 115, 116. No time 
dependent attenuation of KDR current (wash out or run down) was observed until 22 min after 
establishment of the whole cell configuration. The portion of the whole cell KDR current 
blocked by Kv1.5 and Kv2.1 antibodies was equivalent to the current blocked by hypoxia, 
since no further inhibition of KDR currents by Kv1.5 and Kv2.1 antibodies was observed in 
hypoxic cells. From this observation, it is clear that both channels conduct the main hypoxia 
sensitive component of the whole cell KDR current in rat PASMC, which has also been 
indicated in previous reports 115;116. However, apocynin treatment of cells under hypoxia 
resulted in the reappearance of Kv1.5 and Kv2.1 specific current formerly blocked by 
hypoxia. Since apocynin has been suggested to be a ROS scavenger in PASMC 143, it can be 
suggested that the reduced function of KDR channels under chronic hypoxic conditions is most 
likely due to increased ROS production. The role of ROS in regulation of pulmonary vascular 
tone is still controversial. Whereas some reports suggested an increase of ROS 29;30 others 
reports suggestsed a decrease under hypoxia 3;25. In this regard, in the current study an 
increased ROS production was observed under chronic hypoxia, whereas the treatment with 
NOX4 siRNA caused a pronounced decrease in ROS production. Along this line, Cogolludo 
et al. have demonstrated that U46619 inhibited Kv currents in rat PASMC by an increase in 
ROS and that treatment of rat PASMC with apocyin reverted this effect 144. The data were 
further supported by the use of NOX4 specific siRNA in rat PASMC which also significantly 
increased the whole cell KDR current under chronic hypoxic conditions. Intriguingly, the 
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stimulatory effect of apocynin and NOX4 siRNA on the whole cell KDR current was observed 
only under chronic hypoxia, whereas under normoxia, apocynin and NOX4 siRNA had no 
significant effect on the KDR current (data not shown). These findings suggest that NOX4 
mediated inhibition of KDR channels is operational only under chronic hypoxia. This fact is 
further strengthened by the up-regulation of NOX4 under chronic hypoxia which can generate 
a large amount of oxidative species such as O2- and H2O2 which may exert an inhibitory effect 
on KDR channel function. In this regard, it has previously been shown that oxidant production 
decreases the activity of cloned shaker K+ channels (Kv1.3, Kv1.4 and Kv1.5), shaw (Kv3.4) 
and an inward rectifier K+ channel (IRK3) in Xenopus oocytes, whereas Kv1.2, Kv2.1 and 
Kv2.2 were resistant to oxidants 145. Similar findings have been reported in frog cardiac 
myocytes and in rat PASMC 144;146.  The action of oxidants on the K+ channel activity is 
conferred by the oxidative modification at key cystine and methionine residues at the N-
terminal inactivation ball domain and pore domain. Oxidants can affect two different 
inactivation mechanisms of Kv channels: involving N-type inactivation, which is mediated by 
N-terminal ball and chain mechanism; and P/C type inactivation which involves constriction 
of the ion conductance pathway. Oxidants can disrupt the N-type inactivation of shaker type 
K+ channels by methionine oxidation 113 and may accelerate P/C type inactivation of shaker 
type K+ channels in the absence of N-type inactivation 147. The kinetics of a calcium activated 
K+ channel (BKca) are also affected by H2O2, where calcium dependent activation of the BKCa 
channel is disrupted by modification of a cysteine residue near the C-terminal calcium bowl 
domain 112.  
 
Against this background, a significantly increased activation of KDR current and a shift 
towards more hyperpolarised potentials by siNOX4 treatment under chronic hypoxia was 
observed. The conductance voltage relationship can be described by the Boltzman equation, 
G/Gmax=1/ (1+e-(V-V1/2)/K)n, where K is the slope factor, V is the test potential and V1/2 is the 
voltage required for half maximal conductance. Using this equation Kv1.5 channels have been 
reported to have V1/2 and K values around -10 mV and 7 mV  respectively, whereas for Kv2.1 
and Kv2.2 channels these values are 10 mV and 5 to 19 mV respectively 148. In this regard, we 
have observed that the activation kinetics of KDR current under chronic hypoxia is very 
similar to that observed for Kv2.1 and Kv2.2 channels. However, the activation kinetics after 
NOX4 siRNA treatment under chronic hypoxia resembles the pattern observed for the Kv1.5 
channel. This finding may indicate that the effect of NOX4-derived ROS production may 
specifically inhibit oxidation-sensitive KDR channels such as Kv1.5, which is in agreement 
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with the previous finding that the Kv1.5 channel is sensitive to oxidant production, whereas 
the Kv2.1 and Kv2.2 channels are resistant to any inhibition by oxidants 145. However, further 
investigations are required to understand the ROS mediated inhibition of the KDR channels 
under chronic hypoxia. 
6.5 Role of NOX4 in regulation of calcium influx under chronic hypoxia 
  
Calcium is an important intracellular signaling molecule responsible for various physiological 
and pathological processes such as contraction, cell growth and proliferation, gene expression 
and vascular remodeling 55. Calcium homeostasis in the cell is achieved by the presence of at 
least three different categories of Ca2+ channel which are: 1) voltage dependent Ca2+ channels 
(VDCC) such as L-type Ca2+ channels which are regulated by changes in membrane potential, 
2) receptor operated Ca2+ channels (ROC) which are activated by the interaction of agonists 
with the respective receptors such as ryanodine receptor Ca2+ release channels in the 
endoplasmic reticulum (ER), and 3) store operated Ca2+ channels (SOC) which are opened by 
depletion of Ca2+ from ER and lead to influx of Ca2+ ions from extracellular source, a 
mechanism known as capacitative Ca2+ entry (CCE) 149. Recent investigations have suggested 
that calcium regulation in PASMC in response to hypoxia is an intricate signaling process 
involving a cross talk between extracellular calcium influx and intracellular calcium release. 
This complex signaling network of calcium regulation is due to the presence of multiple Ca2+ 
channel present in the plasma membrane which differ in their regulatory mechanism by 
different stimuli. Moreover, presence of intracellular calcium stores such as ryanodine 
sensitive calcium stores in the ER, IP3 sensitive calcium stores and mitochondria further 
increases this complexity. It is suggested that chronic hypoxia induced vascular remodeling is 
mediated by increased levels of calcium in PASMC 55. Many reports have been published on 
the regulation of calcium influx under chronic hypoxia in the last decade which has greatly 
enhanced our understanding of calcium regulation during chronic hypoxia. But still there are 
many unresolved questions: 1) it is not clear yet what is the primary stimulus mediating 
calcium influx during acute HPV, 2) which calcium channels are responsible for maintaining 
increased calcium levels during chronic hypoxia and how they are regulated. Focussing on the 
regulation of calcium influx during chronic hypoxia, the role of NADPH oxidase generated 
oxidative stress was investigated in these processes in rat PASMC on ET-1 stimulation. 
Previous reports have suggested that ET-1 is up-regulated during chronic hypoxia induced 
pulmonary hypertension, and stimulates a biphasic calcium response in PASMC, consisting of 
a rapid transient peak followed by a sustained increase in intracellular calcium levels 13;150. 
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This biphasic response has been suggested due to a complex signaling process involving 1) 
calcium influx via L-type calcium channels due to ET-1 mediated inhibition of Kv channels 
and 2) calcium release from intracellular ryanodine and IP3 sensitive calcium stores by a 
calcium induced calcium release (CICR) mechanism 151. In this regard, a very similar biphasic 
response to ET-1 stimulation was observed in rat PASMC in the current investigation. 
Moreover apocynin treatment of rat PASMC abolished the ET-1 stimulated transient calcium 
increase and delayed the sustained increase in calcium. In addition, the overall ET-1 
stimulated calcium influx under chronic hypoxia was lower in apocynin treated PASMC 
compared to the DMSO treated controls. These findings were further supported by the use of 
NOX4 specific siRNA which decreased the ET-1 stimulated calcium influx under normoxic 
conditions and abolished it completely under chronic hypoxia. These data thus provide the 
evidence that ET-1 mediated calcium influx under chronic hypoxia is mainly mediated by 
NOX4 derived ROS production. However, under normoxic conditions, there could be 
additional regulatory mechanisms which could regulate ET-1 mediated calcium influx 
independent of NOX4. The specific role of NOX4 derived oxidative stress in regulation of 
calcium influx under chronic hypoxia is also in agreement with the real time PCR data which 
revealed a selective up-regulation of NOX4 in chronic hypoxic mouse lung homogenate. 
Analogous to these findings, Rathore et al. have recently reported that the acute hypoxia 
mediated increase in calcium levels was attenuated after apocynin treatment and in isolated 
PASMC from p47 phox knockout mice 50. 
 
According to the classical theory of redox oxygen sensing, the L-type calcium channels are 
responsible for the calcium influx during acute HPV and may also be responsible for 
sustaining increased calcium levels in PASMC during chronic hypoxia 24. Supporting this 
hypothesis some reports have suggested that blockers of L-type calcium channels such as 
nifedipine and verapamil attenuate hypoxia induced pulmonary hypertension 152. In contrast, 
another group reported that nifedipine did not affect hypoxia induced pulmonary hypertension 
in chronically hypoxic rats 153. However, it has been recently recognised that under chronic 
hypoxic conditions besides L-type calcium channels, other calcium channels such as store 
operated and receptor operated calcium channels are important regulators of the calcium 
influx 150, 93. The classical transient receptor potential channels (TRPC) constitute the 
alternative pathways of calcium entry in PASMC. Seven members are included in TRPC gene 
family (TRPC1-TRPC7). Of these, TRPC1 exhibits store operated calcium entry whereas 
TRPC3 and TRPC6 are involved in receptor operated calcium entry. Lin. et al have 
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demonstrated that TRPC1, TRPC3 and TRPC6 are expressed in rat PASMC whereas TRPC1 
and TRPC6 are up-regulated under chronic hypoxia 93. Furthermore, recently published data 
from our laboratory showed in TRPC6 knockout a complete disappearance of the acute phase 
of hypoxia induced pulmonary vasoconstriction 54. 
 
To date, there is no report in the literature which suggests the role NOX4 in regulation of 
calcium influx under chronic hypoxia. In this regard the current study demonstrated for the 
first time an essential role of NOX4 in ET-1 mediated calcium influx under chronic hypoxia. 
However, the mechanism of NOX4 mediated regulation of calcium influx has to be further 
investigated. It is also not clear if NOX4 regulates the calcium influx from the extracellular 
milieu or the release of calcium from the intracellular stores under chronic hypoxia. Possible 
mechanisms may include ET-1 mediated activation of NOX4 in the ER or plasma membrane 
resulting in superoxide production which can increase the calcium influx via TRPC channels, 
L-type calcium channels or from intracellular compartments such as ryanodine sensitive and 
IP3 sensitive calcium stores (Fig. 28). Regarding this possibility an increased ROS production 
was observed in PASMC on ET-1 stimulation under chronic hypoxia. Moreover, ET-1 
stimulated ROS production was significantly decreased in PASMC treated with NOX4 
siRNA. Along this line it has been demonstrated previously that ET-1 can increase ROS 
production by NADPH oxidase activation and can also increase the open probability of L-type 
calcium channels 97;154;155. Moreover, oxidants such as hydrogen peroxide have recently been 
shown to accelerate calcium release from intracellular stores in rat PASMC and NOX4 has 
been shown to produce a large amount of hydrogen peroxide 156;157. In contrast to this, a 
reduced ET-1 stimulated calcium influx was observed under chronic hypoxia in spite of a 
NOX4 up-regulation. The potential reason behind this discrepancy could be high levels of 
calcium which can activate some adaptive mechanisms inside the hypoxic PASMC to prevent 
further calcium increase by oxidative stress coming from NOX4 (Fig. 28). For example, 
Shimoda et al. have shown that high levels of calcium may desensitise ryanodine sensitive 
calcium channels in ER. Thus, calcium induced calcium release (CICR) from intracellular 
stores is inhibited 150. Nevertheless, NOX4 seems to be essential for ET-1 stimulated calcium 
release under chronic hypoxia. However, a complete understanding of this mechanism 
requires further investigation. 
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Fig.28 Schematic presentation of NOX4 mediated regulation of KDR channels and calcium influx under 
chronic hypoxia in PASMC. Under chronic hypoxia an up-regulation of NOX4 can inhibit KDR channel 
function possibly by oxidative modification of cysteine residues due to increased ROS production and regulating 
N-type inactivation or P/C type inactivation. In addition, NOX4 derived ROS production may regulate calcium 
influx via affecting voltage dependent calcium channels (VDCC) such as L-type calcium channels, canonical 
transient receptor potential channels (TRPC) or through the ryanodine sensitive calcium release channels in 
endoplasmic reticulum (ER). High intracellular calcium concentration can lead to vascular media proliferation 
and pulmonary hypertension. SOD- superoxide dismutase; CICR- calcium induced calcium release. 
 
In conclusion, presented data in the current study suggest that 1) NOX4 is significantly up-
regulated in pulmonary arterial vessels during chronic hypoxia, both at the transcriptional and 
protein levels, 2) NOX4 plays an important role in regulating PASMC proliferation, 3) NOX4 
may be involved in the pathogenesis of IPAH, 4) NOX4 derived ROS inhibit KDR channel 
function under chronic hypoxia and 5) NOX4 is important for the ET-1 mediated calcium 
influx under chronic hypoxia. 
 
Together these findings suggest a role for NOX4 and its downstream signaling pathway in 
chronic hypoxia-induced vascular remodeling process. With regard to the up-regulation of 
NOX4 in hypoxia-induced pulmonary hypertension and IPAH patients, a functional 
interference with NOX4 or its down-stream pathway may offer a new therapeutic approach 
for the treatment of this disease. However, further investigations, for example on NOX4 are 
needed to fully prove the relevance of NOX4 in pathogenesis of hypoxia-induced pulmonary 
hypertension. 
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7 SUMMARY 
 
The pulmonary vasculature has the unique ability to undergo vasoconstriction in response to 
acute hypoxia, a physiological mechanism known as hypoxic pulmonary vasoconstriction 
(HPV). Sustained or chronic hypoxia, however, leads to proliferation of vascular smooth 
muscle cells of pulmonary arterioles, which causes a permanent increase in pulmonary 
vascular resistance, and may lead to right heart dysfunction. The underlying mechanisms of 
vascular proliferation under chronic hypoxia have not been fully defined. The NADPH 
oxidases are one family of recently discovered molecules which generate reactive oxygen 
species (ROS) and have been suggested to be important for cellular signaling under 
physiological conditions. However, NADPH oxidase generated oxidative stress can also lead 
to inflammation, vascular smooth muscle cell proliferation and endothelial damage under 
pathological conditions. Many homologs of NADPH oxidases exist, the classical homolog is 
gp91phox or NOX2, and the recently discovered homologs include NOX1, NOX3, NOX4, 
NOX5, DUOX1 and DUOX2. Superoxide production by classical gp91phox is induced by 
assembly of the cytosolic subunits such as p40phox, p47phox and p67phox with membrane-
bound gp91phox complex. A previous report from our laboratory has shown that the knockout 
mice of p47phox subunit exhibit reduced acute HPV as compared to wild type mice suggesting 
an essential role of NADPH oxidases in regulation of vascular tone in acute hypoxia. Against 
this background, the current thesis aimed to elucidate the role of NADPH oxidases in vascular 
remodeling in chronic hypoxia, and its possible downstream mediators.  Screening of 
NADPH oxidase expression revealed that all subunits were expressed in the lung homogenate 
and that NOX4 was prominently up-regulated under chronic hypoxia. The NOX4 mRNA was 
also up-regulated in the microdissected vessels of mice exposed up to three weeks of chronic 
hypoxia. In addition, a functional interference with NOX4 using NOX4 siRNA resulted in 
reduced ROS production and reduced proliferation of pulmonary arterial smooth muscle cells 
(PASMC) revealing an important contribution of NOX4 in PASMC proliferation and 
particularly in hypoxia induced pulmonary hypertension. Intriguingly, a similar reflection was 
found in lungs of patients with idiopathic pulmonary hypertension that underwent lung 
transplantation. Further experiments demonstrated that NOX4 inhibited voltage-gated delayed 
rectifier K+ channels (KDR) under hypoxia. Pharmacological inhibition with apocynin and 
genetic ablation with NOX4siRNA resulted in increased KDR current under hypoxia. In 
addition, the current study demonstrated that NOX4 is essential for ET-1 mediated calcium 
influx in PASMC as NOX4 knockdown using NOX4 siRNA abolished the ET-1 mediated 
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calcium influx under chronic hypoxia.  Thus, the NOX4-ROS-KDR-[Ca2+] pathway may 
contribute to the development of pulmonary hypertension. 
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8 ZUSAMMENFASUNG 
Das pulmonale Gefäßsystem besitzt die besondere Eigenschaft, auf akute Hypoxie mit einer 
Vasokonstriktion zu reagieren. Dies ist ein physiologischer Mechanismus, der als hypoxische 
pulmonale Vasokonstriktion (HPV) bezeichnet wird. Anhaltende oder chronische Hypoxie 
führt darüberhinaus zu einer Proliferation der Media der Lungenarteriolen, das einen 
permanenten Anstieg des pulmonalen Gefäßwiderstandes auslöst, der im weiteren zu einem 
Cor pulmonale führen kann. Die der HPV zu Grunde liegenden Mechanismen sind bisher 
noch nicht umfassend geklärt worden. NADPH-Oxidasen sind eine vor kurzem entdeckte 
Proteinfamilie, die reaktive Sauerstoffspezies (ROS) generieren können und unter 
physiologischen Bedingungen für die zelluläre Signaltransduktion wichtig sind. Andererseits 
können die von NADPH-Oxidasen stammenden ROS unter pathologischen Bedingungen zu 
Entzündung und Proliferation von vaskulären glatten Muskelzellen und zur Schädigung des 
Endothels führen. In der Literatur sind mehrere Homologe von NADPH-Oxidasen 
beschrieben, wobei das klassische Homolog als gp91phox oder NOX2 bekannt ist. Weitere, 
erst kürzlich entdeckte Homologe umfassen NOX1, NOX3, NOX4, NOX5, DUOX1 und 
DUOX2. Die Superoxidproduktion der klassischen gp91phox wird durch die Anlagerung der 
zytosolischen Untereinheiten p40phox, p47phox und p67phox an gp91phox induziert. Unsere 
bisherigen Daten zeigen, dass Mäuse mit einer p47phox-Defizienz im Vergleich zu Wildtyp-
Mäusen eine geringere akute HPV aufweisen, das auf eine essentielle Rolle der NADPH-
Oxidasen für die Regulation des vaskulären Tonus unter akuter Hypoxie hinweist. 
Ziel der vorliegenden Arbeit war, die Rolle der NADPH-Oxidasen für den vaskulären 
Umbauprozess unter chronischer Hypoxie und deren Signaltransduktionsmechanismen 
aufzuklären. Untersuchungen der NADPH-Oxidasen Expression zeigten, dass alle 
Untereinheiten im Lungenhomogenat exprimiert waren und die Expression von NOX4 unter 
chronischer Hypoxie stark hochreguliert war. Darüberhinaus war die NOX4-mRNA auch in 
den durch Mikrodissektion gewonnenen Gefäßen der Mäuse, die 3 Wochen unter chronischer 
Hypoxie gehalten wurden, hochreguliert. Zusätzlich bewirkte eine funktionelle Interferenz 
von NOX4 mit NOX4-siRNA eine reduzierte ROS-Produktion und eine verringerte 
Proliferation der pulmonalarteriellen glatten Muskelzellen (PASMC). Dies weist auf eine 
bedeutungsvolle Rolle von NOX4 für die Proliferation von PASMC, insbesondere bei 
Hypoxia-induzierter pulmonaler Hypertonie, hin. Interessanterweise wurden ähnliche 
Ergebnisse in Lungen von Patienten mit idiopatischer pulmonaler Hypertonie nach 
Transplantation der Lunge gewonnen. Weitere Experimente zeigten, dass NOX4 unter 
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chronischer Hypoxie die voltage gated delayed rectifier K+-Kanäle (KDR) hemmt. Eine 
pharmakologische Inhibition von NOX4 mittels Apocynin oder eine genetische Ablation 
durch siRNA erhöhten den KDR-Strom unter chronischer Hypoxie. Zusätzlich ist in der 
vorliegenden Arbeit gezeigt, dass NOX4 essentiell für den ET-1 vermittelten 
Kalziumeinstrom ist, da durch Reduzierung von NOX4 mittels NOX4 siRNA der ET-1 
vermittelte Kalziumeinstrom unter chronischer Hypoxie nicht mehr vorhanden war.  
Zusammengefasst gesagt, könnte der NOX4-ROS-KDR-[Ca2+]-Signalweg somit zur 
Entstehung der pulmonalen Hypertonie beitragen. 
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9 ABBREVIATIONS 
 
Apo                    apocynin 
AOS                   activated oxygen species 
ADP                   adeonsine di-phosphate 
ATP                    adenosine triphosphate  
BSA      bovine serum albumin 
CCE                    capacitative calcium entry 
cGMP                 cyclic guanosine monophosphate 
cADPR               cyclic adeonsine di-phosphate riobse 
CO                      carbon mono oxide 
CYP                    cytochrome p-450 
[Ca2+]i                 intracellular calcium concentration 
DMSO     dimethylsulfoxide 
DUOX                dual oxidase 
EDTA                 ethylenediaminetetraacetic acid 
EETs                   epoxyeicosatetraenoic acid 
EGTA      ethylene glycol-bis (2-aminoethylether)-N,N,N’,N’-tetraacetic acid 
EMSA                electromobility shift assay 
ER                      endoplasmic reticulum 
ET-1      endothelin-1 
ETC      electron transport chain 
FCS      foetal Calf Serum 
FITC      fluorescein Isothiocyanate 
g      gramm 
G      gauge 
H2O2                    hydrogen per oxide      
HETEs                hydroepoxyeicosatetraenoic acid 
HIF                     hypoxia Inducible Factor 
HO                      heme oxygenase 
HOX                   hypoxia   
HPV      hypoxic Pulmonary Vasoconstriction 
HRE                    hypoxia responsive element 
IPAH                   idioptathic pulmonary arterial hypertension 
BKCa2+               calcium activate potassium channel 
K+                       potassium ion 
KA                      A-type potassium channel 
KDR                    delayed rectifier potassium channel 
Kir                      inward rectifier potassium channel   
K+ATP               ATP sensitive potassium channel   
kg      kilogramm 
Kv-channel     voltage-dependend potassium channel 
l      liter 
M      molar 
mRNA                messenger ribo nucleic acid 
ml      milliliter 
mM      millimolar 
μM      micromolar 
n      number of experiments 
NADP                 nicotinamide adenine di-nucleotide phosphate (oxidised) 
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NADPH              nicotinamide adenine di-nucleotide phosphate (reduced) 
nM      nanomolar 
NO                      nitric oxide 
NOS                    nitric oxide synthase 
NOX                   normoxic 
NOX1                 NADPH oxidase homolog 1 
NOX2                 NADPH oxidase homolog 2 (gp 91phox)    
NOX4                 NADPH oxidase homolog 4 (Renox) 
O2-                 superoxidradikal 
O2                 oxygen 
OH-                     hydroxyl radical     
PASMC     pulmonary Arterial Smooth Muscle cells 
pA/pF                 current density  
PBS      phosphatpufferlösung 
Po                       open probability of channel   
pCO2      partial pressure of carbon di-oxide 
pO2                     partial pressure of oxygen    
ps                        pico siemens 
PAP                    pulmonary arterial pressure 
PIP2      phosphatidylinositolbisphosphate 
PKC      proteinkinase C 
PKG                    proteinkinase G  
RT-PCR              reverse transcriptase polymerase chain reaction   
PLC      phospholipase C 
pVHL                 von Hippel-Lindau   
ROC      receptor-operated Ca2+channel  
ROS      reactive oxygen species 
RyRs                   ryanodine receptors 
rpm      revolution per minute 
sGC                     soluble guanylyl cyclase       
siRNA                 small interfering RNA 
SEM      standard error of mean  
SOD                    super oxide dismutase 
SR                       sarcoplasmic reticulum  
TWIK                  weakly inward rectifying potassium channel     
SMC      smooth muscle cell  
SM- Actin        alpha-smooth muscle actin  
SOC      store-operated Ca2+channel  
U      units 
VDCC voltage-dependent Ca2+ channel  
Vm                      membrane potential  
WT      wildtype 
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